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ABSTRACT
Severe sepsis kills an estimated 1,400 people worldwide every day. This often fatal
infectious process accounts for an estimated 215,000 deaths in the United States (US) annually.
The main goal of this project was to evaluate the impact of the Emergency Department
Severe Sepsis Alert and Practice Protocol (EDSSAPP) post implementation, on time to first
antibiotic administration, length of stay, and mortality in patients admitted via the ORMC ED
with severe sepsis.
This study evaluated the time to first antibiotic administration, total ED and hospital
length of stay (LOS) and mortality of severe sepsis patients either with a severe sepsis alert
(SSA) activated or no alert activated that were admitted to the hospital through the ED. A
retrospective review of the electronic medical record (EMR) was conducted to gather the
required data across three time cohorts: base line/time zero (T0), six months prior to the
implementation of EDSSAPP; Time one (T1) the first six months following initial EDSSAPP
implementation; and Time two (T2), six months following reinstatement of the corporate sepsis
committee.
The most significant finding of this study was the increased number of Severe Sepsis
Alerts activated in time cohort T2 (n=113) compared to T1 (n=19). Another important finding
was the decreased mortality in T2 (16.4%) compared to T0 (22.7%) and T1 (33%). Overall, the
number of ED patients with severe sepsis who received antibiotics within the EDSSAPP required
60 minutes did not consistently improve across the three time cohorts, T0 (81.8%), T1 (71.7%)
and T2 (80.6%).
The hospital LOS of stay was increased by almost 1.5 days between those patients with a
severe sepsis alert activated in T1 (9.00 days) compared to time T2 (10.48 days). There was no
iii

significant decrease in the ED LOS across time cohorts and between groups of patients who had
a SSA activated versus no alert activated. However, there was a 1 hour and 28 minute decrease
in ED LOS in patients who had a severe sepsis alert activated in T1 compared to T0. In addition,
there was a 1 hour and 52 minutes decrease in ED LOS between patients who had a SSA
activated compared to those who had no alert activated in T2.
While EDSSAPP data does not demonstrate the statistically significant results that was
expected, the challenges related to adherence by providers to EDSSAPP is as it is seen in the
literature. Increased awareness via consistent communication of on-going audit results to ED
personnel will heighten their awareness for severe sepsis and EDSSAPP. Improved collaborative
efforts with the interdisciplinary team are needed to refocus everyone’s efforts to increase early
recognition that is followed by appropriate treatment interventions and documentation is
essential. Lastly, the development of a formal process to follow up with individual providers as
close to real time as possible following a SSA that includes accountability for care provided and
related documentation would also contribute to both awareness and adherence.
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CHAPTER ONE: INTRODUCTION
Background/Scope of the Problem
Severe sepsis, commonly known as blood poisoning, is a serious health threat killing an
estimated 1,400 people worldwide each day (http://ssc.sccm.org/background/worldsoldestkiller
retrieved 7/4/12). Sepsis is the 10th leading cause of death in industrialized countries, killing as
many people each year as does acute myocardial infarctions (Marshall, 2008). In addition, it is
suspected that 80% of patients who died from major injuries actually succumbed from severe
sepsis (http://ssc.sccm.org/background/worldsoldestkiller). Despite substantial research and
significant advances in technology and treatment, severe sepsis continues to be deadly, with
mortality rates ranging from 30 to 50% (Shorr, Micek, Jackson & Kollef, 2007). This fatal
infectious process accounts for an estimated 215,000 deaths in the United States (US) annually
(Rezende et al., 2008). From 1999 to 2005 approximately 6% of all US deaths were related to
severe sepsis; however, it is important to note that secondary to documentation and reporting
variances, the National Center for Health Statistics believes that this number may be grossly
underestimated (Melamed & Sorvillo, 2009). Data from 2009 demonstrate that in the US alone,
the economic and social burdens to society resulting from the direct costs of caring for the severe
sepsis patient population is approximately $17 billion (Silva & Araujo, 2009). The indirect costs
to society are thought to be somewhere between $34 and $51 billion annually As the US
population continues to age, deaths from severe sepsis are only expected to increase (Melamed &
Sorvillo, 2009). Severe sepsis was the leading cause of death for hospitalized patients in the US
between 2003 and 2007 with the number of in-patient deaths increasing an alarming 35% and
associated hospital costs increasing an estimated 57% (Lagu et al., 2012).
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The History and Definition of Severe Sepsis
As early as 400 BC, Hippocrates described sepsis by saying that living tissue could be
broken down in the body by one of two very different ways (Marshall, 2008). The first he called
Pepsis; this was a healthy process, one that resulted in digestion of food and in nature caused the
fermentation of grapes into wine. The second process he called Sepsis, where flesh becomes
rotten and wounds festered. Hippocrates considered sepsis an evil process producing disease in
man. In nature sepsis was thought to be responsible for the stench in swamps. These beliefs, as
expressed by Hippocrates stood as one basis for understanding diseases for two thousand years.
Another contribution to the understanding of sepsis was described by Galen of Pergamon (130 –
200 AD). Galen named the “cardinal signs of inflammation: rubor, calor, dolor and tumor” (p.
471). Red, hot, and painful are today still considered the signs of an infectious process. A fifth
symptom of inflammation, loss of function, was later added by Celsius. Hippocrates, Galen and
Celsius’s conclusions remain foundational concepts regarding how diseases inflicted humans and
caused life threatening physiological changes until the late 1800’s when the Pasteur Institute of
France began the tedious task of exploring and understanding the complex microbial
pathophysiology of infections.
Despite the medical community’s growing knowledge of infectious diseases, there
continues to be challenges encountered when caring for septic patients. Rather than addressing
each patient’s unique immune response to the infectious process, the treatment for this patient
population has continued to focus on ways to identify and kill the invading organisms.
According to Warren (2010) “it isn’t the replication of bacteria in animals or humans that kills
us, but rather the consequences related to the inflammatory response” (p.14). He goes on to
describe the septic patient’s response to this process as a delicate balance between the patient not
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responding with enough inflammation to fight the invading microbes as in the immunecompromised patient or in patients with a chronic infectious process. In contrast, Warren noted
that the patient who experiences an excessive inflammatory response may rapidly advance into
severe sepsis. Therefore, health is not only the lack of disease, but also regulation of the body’s
inflammatory response to the presence of foreign organisms. The patient’s symptoms of sepsis
are not initially caused by any injury or damage directly from the invading organisms, but rather
the physiological response to the presence of organisms in the body. This conclusion supports
the concept that, at least initially, the patient’s symptoms are a result of the invasion, and not
widespread cellular damage from the offender. This new perspective increases the opportunities
for innovative treatment possibilities (Marshall, 2008). While the patient’s actual inflammatory
response is responsible for symptoms of severe sepsis, identifying the exact initial cause or any
contributing immune system compromise leading to the rapid advancement of the illness may
not be easily identified.

The Symptoms and Treatment of Severe Sepsis
It is important to note that there is no one single organism responsible for severe sepsis.
These infections may be caused by bacteria, viruses or fungi (Martin, Mannino, Eaton & Moss,
2003). The symptoms of severe sepsis such as an altered mental status, tachycardia, fever, and
hypotension are also seen in many other medical conditions; therefore caution must be taken in
order to avoid misdiagnosis. Treating these patients by choosing the most effective antimicrobial
medication to counteract the suspected cause of the illness is not a simple decision. Healthcare
providers must, like a puzzle, analyze the symptoms and maintain a high index of suspicion for
sepsis. The healthcare provider is also obligated to consider many additional treatment options
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and choose the interventions that they believe will achieve a positive outcome. On occasion,
there are legitimate concerns that treatment decisions are made based on traditional approaches,
rather than current evidence (Kollef &Micek, 2010). Treatment can be focused on reducing the
patient’s systemic inflammatory response or may be aimed at killing the identified invading
organism (Bone et al., 1992), or both. In 2005, the American Thoracic Society and the Infectious
Disease Society of America collaborated to identify the most appropriate antimicrobial therapy
for the treatment of nosocomial pneumonia. While choosing the appropriate antimicrobial may
appear to be a simple concept, the recommending group believed there was clear evidence to the
contrary based on evidence of poor patient outcomes. In addition to choosing the most
appropriate antimicrobial agent, the timing of this treatment has also been determined to be an
important key to the patient’s chance for survival. Every hour that passes without the
administration of the appropriate antimicrobial mediation the patients chance of survival
decreases 7.6%.
Severe sepsis creates a wide variety of symptoms which can mimic many other medical
conditions, making a definitive diagnosis and initiating treatment an ongoing challenge
(Raghavan & Marik, 2006). In addition, each individual patient’s response to the invading
microbes is also influenced by many contributing factors such as the patient’s age, the status of
the immune system, and the presence of any pre-existing co-morbidities. There is however, no
question that severe sepsis can lead to single or multiple organ dysfunction, multisystem organ
failure, and death, and the number of lives lost secondary to sepsis can be reduced using the
Surviving Sepsis Campaign (SSC) guidelines. A worldwide campaign was launched to provide
education and improve compliance with these guidelines for the treatment of sepsis.
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The Surviving Sepsis Campaign
The established signs of inflammation, along with the understanding of microbes as
causes of sickness, have remained basic fundamental theories of infections until the Barcelona
Declaration in 2002. This conference resulted in increased attention to severe sepsis and spurred
new interest and an increased the sense of urgency to learn more and find answers (Marshall,
2008). At this international meeting of intensive care specialists, members of three of the world’s
leading professional medical organizations – the European Society of Intensive Care Medicine,
the Society of Critical Care Medicine (SCCM), and the International Sepsis Forum joined forces
to work together to improve both the recognition and the treatment of severe sepsis. This united
group of healthcare professionals acknowledged the costs to the world’s society were high both
in the number of human lives lost and the corresponding societal financial burden. This group
agreed that increased awareness by healthcare providers was an absolute necessity to achieve an
early and accurate diagnosis of severe sepsis followed by the appropriate and timely treatment.
The Barcelona Declaration had one simple yet ambitious primary objective: improve severe
sepsis patient survival by 25% worldwide by 2009 (Rivers & Ahrens, 2008). The SSC was
developed and the group elected to move forward in four phases.
Phase one began in October of 2002 following the Barcelona Declaration. After both
discussion and debate the group agreed that the universal definition of severe sepsis was the
body’s systemic response to an overwhelming infection resulting in hypo-perfusion that can
rapidly cause organ failure and death (Bone et al., 1992). The phase one goal was to globally
communicate and educate by publishing the SSC components related to the importance of early
recognition and treatment of severe sepsis.
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The SSC second phase began in 2003 when selected international experts in critical care
and infectious disease collaborated to develop and publish severe sepsis treatment guidelines
(http://www.survivingsepsis.org/guidelines/Pages/default.aspx). In early 2004 these guidelines
were completed and recommended for adoption and implementation into clinical practice for this
patient population. The guidelines were up-dated in 2008 and a summary of these guidelines are
presented in Appendix A. While the SSC guidelines were again updated and released in the
Spring of 2013 it is the 2008 guidelines that will be used for this study as these were the
guidelines available during the inception and implementation of Emergency Department Severe
Sepsis Alert and Practice Protocol (EDSSAPP) in the participating facility.
The main objective of phase three was for the consortium promoting SSC to collaborate
with the Institute for Healthcare Improvement (IHI), a not-for-profit independent organization
whose main focus is helping leaders and healthcare providers worldwide to find ways to change
the delivery of care in order to provide both safe and quality care to all who access the healthcare
system (http://www.ihi.org/explore/Sepsis/Pages/default.aspx). Through this strategic
partnership, sepsis bundles were developed using the evidence-based guidelines previously
introduced in the SSC. A bundle consists of a group of evidence-based interventions that when
implemented together can improve the patient’s outcomes. Bundles have become an important
tool for health care providers. One important goal in developing the sepsis bundle was to make it
user friendly and easy for providers to implement into their daily practice. The concept of Early
Goal Directed Therapy (EGDT) was first described for the treatment severe sepsis and septic
shock patients by Rivers et al. in 2001. Jones, Shapiro & Roshon, (2007) identified the unique
challenges faced by ED’s in both community and academic medical facilities in implementing
EGDT. This study noted that severe sepsis and septic shock had high mortality rates along with
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significant facility resource utilization. In addition, they concluded that early recognition
combined with EGDT improved patient outcomes. EGDT in severe sepsis and septic shock is an
important tool to improve patient outcomes and saves lives. The key to implementation of EGDT
is dependent on the clinician’s ability to recognize the patient as having severe sepsis or septic
shock. Part of this recognition includes evaluating the patient for specific criteria as defined in
the SSC guidelines, such as a serum lactate greater than four, a systolic blood pressure less than
90 mm Hg and a change in level of consciousness. According to Dellinger et al. (2008) early
goal-directed resuscitation improves survival for emergency department patients presenting with
septic shock.
In addition, a central data collection process was developed by the SSC program
(http://www.survivingsepsis.org/Data-Collection) so that participating facilities worldwide could
enter information and results to determine if the SSC was making a difference and improving the
care of severe sepsis patients. Tools were developed as a resource for users to produce graphs of
their facilities’ data to help demonstrate their improvements
(http://www.survivingsepsis.org/Resources/Pages/default.aspx). SSC guidelines and bundles
were reviewed, revised and updated along with links provided on the websites where the most
current sepsis information can be obtained. One link provided on the site is to the Advances in
Sepsis (http://www.advancesinsepsis.com/) web site that has many of the current international
leading medical experts as contributing authors.
Phase four includes continuing to update the SSC program based on new evidence, as
well as continuing the efforts to educate healthcare providers worldwide. In addition, an analysis
of the data entered into the SSC website from 15,000 severe sepsis patient records was conducted
and published: The Surviving Sepsis Campaign: Results of an international guideline-based
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performance improvement program targeting severe sepsis (Levy et al., 2010). This analysis
validated results that patient outcomes were improved when SSC bundles were implemented.

The Role of Evidence-Based Practice in the Treatment of Severe Sepsis
Providing safe and quality patient care is a foundational principle for healthcare today
and one important way to accomplish this is through the use of evidence-based practice (EBP).
This term was first discussed in 1972 by the English medical researcher, Dr. Archie Cochran
(Melnyk & Fineout-Overholt, 2011). Dr. Cochran strongly believed the best empirical evidence
to support appropriate care came from randomized clinical trials. He further contended that there
should be systematic and rigorous reviews of research in order to find the most effective
treatments. It is important for healthcare providers today to combine EBP with sound clinical
judgment and collaboration with the patient (Dontje, 2007). While there are still some healthcare
providers who continue to feel that EBP is a “cookie cutter approach,” professional healthcare
organizations have embraced it, issuing best practice guidelines based upon EBP principles.
In addition, EBP has become an accreditation standard and incorporated into
accreditation review by agencies such as The Joint Commission (TJC). As an example, TJC
establishes National Patient Safety Goals based on merit, cost and effectiveness. These goals are
promoted as an accreditation standard and enforced through the accreditation review process.
Implementation of EBP requires interdisciplinary collaboration between healthcare
professionals. It is integral to patient care management and impacts patient outcomes. Almost
70% of patient adverse events occur due to lack of collaboration and communication between
providers (Fewster-Thuente & Velsor-Friedrich, 2008). Collaboration and communication are
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improved with the use of standardized, evidence-based guidelines developed through an
organized process.
Multiple frameworks have been provided intended to organize process of developing
evidence-based guidelines. Examples include those proposed by Melynk and Fineout-Overholt
(2011), Rosswurm and Larrabee (1999), Stetler (2001), and Johns Hopkins Hospitals and Clinics
(Newhouse, Dearholt & Poe, 2005). The Iowa Model (Figure 1) is representative of the
processes discussed in these models. This model is used/reprinted with permission from the
University of Iowa Hospitals and Clinics and Marita G. Titler PhD, RN, FAAN, copyright 1998
(Appendix B). It offers the healthcare provider a logical sequential flow to follow in an easy to
read algorithm. In 2010 the Advanced Practice Nursing department at Orlando Health adopted
the Iowa model as the preferred process to follow when considering the implementation of EBP
process changes at this system. It is important to note that the Iowa model was not used during
the development of EDSSAPP as this process was initiated in 2009 prior to the model’s selection
by this healthcare system.
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Figure 1: The Iowa model of evidence-based practice to promote quality care

10

The following discussion is a comparison of the EDSSAPP process development with the
steps of the Iowa model. This review was conducted in order to determine if the EDSSAPP
process development correlated with EBP implementation guidelines as seen in the Iowa model.
This evaluation demonstrated that the steps followed in EDSSAPP evolution mirrored the Iowa
model up to the point of evaluation and dissemination of results.
The Iowa Model process begins with the identification of a trigger or clinical problem. In
this case Orlando Health, using the SSC materials began looking at ways to improve the early
identification of severe sepsis and combine this with timely and appropriate treatment.
Organizational data confirmed suspicions that severe sepsis was indeed a threat to patients in this
hospital system just as discussed in the international literature. The next step, following this
model, was to determine the relevance of this severe sepsis project to the healthcare
organization’s mission and strategic plan. The significance of severe sepsis at this organization
had previously been acknowledged in 2006 prior to the SCCM’s presentation of the SSC so the
problem or trigger had previously been identified as pertinent and continues to be in line with the
organization’s goal to decrease mortality.
Next, the Iowa Model algorithm calls for the formation of a team to gather and review
evidence related to the identified problem. A multidisciplinary team was formed to develop this
process in the Orlando Regional Medical Center (ORMC) Emergency Department (ED). Once
the literature was evaluated, synthesized and ranked, the team determined what if any practice
changes were necessary. Once this foundational work had been completed, the team agreed on
the desired outcomes and corresponding EBP guidelines and an order set was developed. This
ED’s multidisciplinary team carefully reviewed and discussed the SSC’s initial resuscitation
bundle (Appendix C) addressing the first six hours of care and from these developed EDSSAPP.
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Care was taken to ensure each component of the SSC bundle was reviewed, addressed and
adapted as appropriate in both the treatment protocol and order set developed for implementation
in our ED setting.
The Iowa Model states that the team may determine if it is best to first pilot the proposed
process changes prior to full implementation. A pilot allows for the team to evaluate the process
and to receive feedback from the frontline healthcare providers prior to full implementation. The
ED team determined that the EDSSAPP process being introduced followed similar existing
processes already used in the trauma and cardiac populations; therefore a trial or pilot was not
needed. The next step post implementation is to carefully evaluate if this new process has
changed practice and improved patient outcomes. As there was no pilot of EDSSAPP the next
step for this team was to develop a formal process to continually monitor and evaluate
EDSSAPP data and implement changes as necessary.
The Iowa model’s last step is to recognize and address any identified challenges related
to the changes made or EBP processes implemented. When EDSSAPP was first implemented a
process was put into place to gather data on each of the ED patients that had a Severe Sepsis
Alert (SSA) activated. Despite the collection of SSA patient’s data there has not been any formal
evaluation conducted related to this EDSSAPP data. This study is an objective evaluation of
EDSSAPP and its impact on the severe sepsis patient population in this ED. According to the
Iowa Model it is important for key members of the team to actively, continually and closely
monitor the process and associated data that demonstrate the healthcare team’s adherence to
following the process and determining if any changes are necessary to sustain the evidence based
practice changes. It is essential to communicate the ongoing data results with the entire
healthcare team in order to encourage adherence and move forward to a sustained culture
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change. It is this step in the Iowa Model that this severe sepsis study will complete, an evaluation
and dissemination of the data at different time intervals since its original implementation to
determine the impact it has had on this patient population’s morbidity and mortality in this
healthcare system.

Severe Sepsis Challenges in Emergency Departments
As established, the appropriate treatment of sepsis is time sensitive. Studies conducted by
the SCCM and others have demonstrated the importance of early interventions with standard
practice protocols and guidelines in order to improve outcomes for septic patients. One excellent
example of successful implementation of the SSC program was in 2010 at the Catholic
Healthcare West healthcare system (Rauber, 2010). This facility reported that three years after
implementing the SSC guidelines a reduction of inpatient death rates by 33%, as well as a
decrease on healthcare costs by $36.5 million. Unfortunately, the Emergency Department (ED)
is especially challenged to implement time-sensitive protocols.
Since 1990 the number of hospital-based emergency departments in the U.S. has declined
by 27% while the number of patient visits has increased by 30% (Hsia, Kellermann & Shen,
2011). Between 1998 and 2008 there were more than 123 million visits to our nation’s ED’s. As
the world’s economy continues to struggle, there are increasing numbers of uninsured and
underinsured individuals seeking healthcare in ED’s. The Emergency Medical Treatment and
Active Labor Act (EMTALA), a federal anti-dumping law passed in 1986 requires ED’s to do a
medical screening exam on all patients seeking emergency medical care, regardless of their
ability to pay. These challenging economic conditions make the nations’ ED’s a “safety net” for
the entire healthcare system. As ED patient volumes and acuities continue to increase, so do
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delays in treatments and department overcrowding. It is not uncommon for ED’s to care for
admitted patients for extended periods of time while waiting for inpatient beds to become
available. These throughput challenges can potentially contribute to the quality of care provided
to patients seeking care in the ED. Clark and Normile (2007) noted in a 2003 Government
Accounting Office report that the most common cause of delayed admission to the hospital was
holding admitted patients in the ED due to a lack of critical care bed availability. The ED is
simply not designed or staffed to care for patients over extended periods of time, especially
critically ill or injured patients (Chalfin et al., 2007).

The Orlando Health Project
In response to the call for increased awareness and action, in October 2006 the SCCM
presented the SSC to a select gathering of clinical leaders at Orlando Health. Following this
introduction, corporate-wide teams were formed to develop a system-wide educational program
based on the SSC materials. The primary educational goal was to teach clinical personnel to
“Recognize, Respond and Rescue” septic patients at all the facilities in the Orlando Health
system (Orlando Health Computer Assisted Instruction Program, 2007).
Once the educational process was in place and clinical provider education underway the
next step was to establish teams to evaluate clinical areas for potential process changes that
would include the SSC guidelines. Pertinent to the prominent role of the ED in early detection of
sepsis, in February 2008 the ORMC ED/Level One Trauma Center sepsis team was formed. This
multidisciplinary group included the following ED personnel: clinical pharmacist, phlebotomist,
staff Registered Nurse (RN), Clinical Nurse Specialist (CNS), attending physician, and resident
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physician. In addition, a representative from the hospital data/quality department also
periodically participated.
In September 2009 the finalized Emergency Department Severe Sepsis Alert and Practice
protocol (EDSSAPP) along with an order set based on the SSC guidelines were implemented in
the ED (Appendix D). As recommended by the SSC the multi-disciplinary group that developed
the EDSSAPP guidelines included an algorithm to increase early recognition of severe sepsis
patients and initiation of EGDT. In addition, components of this protocol are intended to
expedite the patient admission process.
Since the implementation of EDSSAPP there has been no formal evaluation of this
process to determine the impact of this EBP-driven project on patient outcomes. For this reason a
snap-shot audit data review was performed in 2010. Data were collected through a retrospective
electronic medical record (EMR) audit of all Severe Sepsis Alerts called from the date of
implementation: September 2009 to August 2010. For comparison purposes baseline data were
also obtained from a retrospective EMR audit for the six months prior to the implementation of
EDSSAPP. The data items collected at pre and post EDSSAPP implementation are noted in
Table 1.

Table 1: Pre and post alert audit data items
Pre Alert

Post Alert

The shift of arrival

The shift of arrival

Gender

Gender

Time of arrival to time of first antibiotic given

Time of arrival to time of first antibiotic given

Average hospital length of stay

Average hospital length of stay
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In order to ensure inter-rater reliability, all data were collected by the ED CNS and one
ED staff nurse who volunteered to assist with the EDSSAPP project.

Early EDSSAPP Findings
As noted in the Table 2, between March and September of 2009 there were 37 patients
admitted through the ED to a monitored unit at this facility with the diagnosis of severe sepsis or
septic shock. For the first six months post implementation of EDSSAPP (from September 2009
to March 2010) there were 49 patients admitted to a monitored unit with the diagnosis of severe
sepsis or septic shock and of these there were only 19 SSA’s called. These data suggest that the
EDSSAPP process was only being utilized approximately 38.7% of the time.

Table 2: Pre and post implementation audit data
Variables

Pre Implementation Data

Post Implementation Data

Time frame and number

3/09 – 9/09: 37 patients

9/09 – 3/10: 49 patients admitted with diagnosis of severe

totals.

admitted with diagnosis of

sepsis/septic shock

severe sepsis/septic shock

30 (61.2%) patients met severe sepsis/septic shock
criteria and had NO ALERT called.
19 (38.7%) met severe sepsis/septic shock criteria and
HAD ALERTS called.

Shift of arrival

7a – 7p: 73%

7a – 7p: 55%

7p - 7a: 27%

7p - 7a: 45%

27% Female

32% Female

73% Male

68% Male

Time of arrival to time

1 hour or less: 0%

1 hour or less: 73%

of first antibiotic given

1-2 hours: 9%

1-2 hours: 14%

2-3 hours: 4.5%

2-3 hours: 4%

3-4 hours: 3.2%

3-4 hours: 9%

Greater than 4 hours: 83.3%

Greater than 4 hours: 0%

10.5 days

7.9 days

Gender

Average hospital length
of stay

16

Discussion of EDSSAPP Audit Findings
Despite the fact that Severe Sepsis Alerts were not being initiated on all patients who met
the criteria, there was improvement in processes related to treating severely septic patients. The
one component that had the most significant change was the time to first antibiotic
administration. The goal was to administer the antibiotic within one hour of the patient’s arrival
to the ED. The audit data demonstrated the numbers went from 0% antibiotics administered
within one hour to 73% of ED severe sepsis patients receiving their initial antibiotics within in
one hour of arrival to the ED. In addition, the data also showed the hospital had an overall
decrease in length of stay for this population from 10.5 to 7.9 days during this time frame. These
audit results were presented in a poster at the annual Emergency Nurses Association’s Scientific
Assembly in 2010 (Appendix E) and inspired the development of this study, ED staff involved in
EDSSAPP determined it was time to have a formal evaluation of this process and decide if any
changes are needed to improve the care of this patient population.

Doctor of Nursing Practice (DNP) Study Purpose
Despite worldwide educational efforts and advances in care, mortality in the sepsis
patient population continues to remain high. While the snap shot audit data presented here
indicates an improvement in the care provided to these patients, a more thorough assessment of
data will assist in determining what, if any changes need to be made to the current educational
programs or to the EDSSAPP process itself. Monitoring and evaluating EDSSAPP process using
the Iowa Model as an organizing construct as discussed earlier will assist in determining the
impact of this process change on patient and organizational outcomes. It is the purpose of this
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thesis to conduct a retrospective analysis of data associated with the SSC campaign in the ED at
ORMC in order to advise the organization and contribute to the profession.
The primary purpose of this study was to assess the effect of EDSSAPP implementation
(alert-activated versus no alert- activated) on the time to first antibiotic administration, ED and
hospital LOS, and mortality in severe sepsis patients admitted to the hospital through the ORMC
ED across three time cohorts: 1) base line time zero (T0): six months prior to EDSSAPP
implementation, 2) time one (T1): the first six months following the initial EDSSAPP
implementation, and 3) time two (T2): six months following the reinstatement of the corporate
sepsis committee.
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CHAPTER TWO: LITERATURE REVIEW
Introduction
The foundations for the literature related to the assessment and treatment of severe sepsis
and septic shock are derived from the 1991 collaborative work of the American College of Chest
Physicians and the Society of Critical Care Medicine. In 1992 their work was added to a global
initiative including efforts from the European Society of Intensive Care Medicine and the
International Sepsis Forum to begin the “Surviving Sepsis Campaign” (Bone, et al., 1992).
Research continues today to look for ways to diagnosis sepsis early and provide the most
effective definitive treatment. As a result there is extensive literature available addressing severe
sepsis and septic shock. Sepsis literature, specifically related to the unique challenges faced by
emergency departments was also plentiful.
Orlando Health’s sepsis initiative did as the SSC recommended, implemented educational
and process changes to “Recognize, Respond and Rescue” this vulnerable patient population.
Information found throughout the literature mirrors the experiences at the ORMC ED during this
process change. Now, following the Iowa model algorithm a study was conducted to determine if
EDSSAPP has positively impacted patient outcomes.
The focus of this chapter is to discuss the review of literature addressing the barriers to
and strategies for developing and implementing process change related to the care of severe
sepsis patients in the ED, evaluate the currently available diagnostic laboratory testing for sepsis,
and analyze post process change successes seen in the ED setting. Appendix F is the Literature
Review Summary table.
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Diagnostic Tools to Determine Severe Sepsis
Patients presenting with symptoms of severe sepsis or septic shock must not only have
the history of their present illness determined, but their comprehensive medical history
accurately obtained as well. One of the valuable tools available to the clinician to assist in
determining the diagnosis of sepsis is laboratory testing. The following three serum tests-Creactive protein (CRP), Lactate, and Procalcitonin (PCT) - are helpful in evaluating and
determining if the patient is septic.
CRP is protein that is normally found in the blood and can be measured when
inflammation is suspected. The challenge the clinician faces is that this level is also increased in
other conditions: surgery, traumatic injuries, burns, or any inflammatory process. Therefore,
CRP can increase the provider’s suspicion for sepsis; however, it is not reliable as a definitive
diagnostic test for sepsis (Lee et al., 2008).
Lactic acid (lactate) is the level of acid in the blood stream and was first measured in
human serum in 1843 by Scherer while describing a patient in septic shock (Jansen et al 2009).
Elevated lactate levels indicate anaerobic metabolism, a condition seen in patients with severe
sepsis and septic shock. The clinician must use caution, however, when using lactate as an
indication of sepsis as elevated levels may also be seen in patients following strenuous exercise,
in patients with liver disease, kidney disease or heart failure. In 2009 Arnold et al. looked at
lactate levels and found that the earlier a patient can normalize the lactate level, the higher the
probability they would survive. The authors’ conclusions were that following a patient’s lactate
levels and making efforts at lowering the value a priority for continued treatment are an
important component of care in the septic patient population. However, Jansen et al. (also in
2009) conducted systematic review of the technology related to lactic acid measurements and its
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reliability in assisting to make a diagnosis of sepsis and found this finding to be questionable.
While this study questioned lactate levels’ reliability in diagnosing severe sepsis, the authors did
agree that this has a place in the assessment and treatment of septic patients and should be just
one tool used to assist, but not replace the clinician’s assessment or clinical judgment. Vanzant
and Schmelzer (2011) also evaluated the use of lactate levels in diagnosing and treating septic
patients and came to a similar conclusion. These authors stated that measuring serum lactate is a
quick and easily obtained laboratory test in the ED and therefore should be included in the
assessment process. While high lactate levels will alert the clinician that this patient is at a
greater risk for mortality it is not specific enough to clearly identify the potential cause of the
patient’s condition. Shapiro et al (2005) noted that identifying sepsis in the ED is a challenge to
clinicians as the signs and symptoms are subtle and currently there is no definitive diagnostic test
available. Shapiro et al. did agree that high lactate levels were clearly associated with higher
mortality in septic patients. In addition, they also found that 4.9% of patients in their study with
sepsis who despite having normal lactate levels died. They concluded that lactate levels, while a
valuable bio-marker in the assessment of these patients is not the reliable as a single diagnostic
test for this patient population.
Procalcitonin (PCT) is another serum laboratory test that may be useful for the clinician
when evaluating potentially septic patients. This is a fairly new inflammation bio-marker that can
be helpful in determining the presence of a bacterial infection. A 2010 a study by de Kruif et al.
conducted in 310 bed teaching hospital compared CRP results in febrile ED patients to the PCT
levels in those same patients. Their findings demonstrated that PCT was more specific for
bacterial infection while the CRP was more sensitive for the presence of inflammation. Used in
combination, PCT and CRP would be valuable additions to the laboratory diagnostic tests for
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patients with suspected sepsis. They did, however, note that common use of PCT as a biomarker has not yet been established as a standard component of care in the ED. A study by Lee
et al. (2008) supported the de Kruif conclusions, noting that PCT can be a valuable laboratory
test for the clinician who suspects sepsis when it is used in conjunction with assessment findings
and clinical judgment.
The literature supports that while there is no single laboratory test currently available to
reliably diagnosis sepsis, multiple tests combined with assessment findings and clinical judgment
are the key in determining if the patient is septic.

Barriers to Implementation of Evidence Based Guidelines
In an effort to encourage use of the SSC guidelines, the 2008 International Guidelines for
the Management of Severe Sepsis and Septic Shock (Dellinger et al.2008) carefully spelled out
in detail the steps in recognizing sepsis. They evaluated the quality of the evidence used to
support the guidelines and treatment options. These recommendations include antibiotic therapy,
source control, intravenous fluid therapy, contemplation of vasopressors, inotropes and
corticosteroids. Each section has a discussion and the rationale for each recommendation. The
information in these guidelines provides the clinician with the necessary tools to understand the
science behind the recommendations so appropriate informed treatment decisions can be made as
expeditiously as possible.
Although the literature supports the utilization of the SSC guidelines to standardize care,
many authors also agree that guidelines are not intended to take the place of the clinician’s
knowledge or experience (Dontje, 2007). The clinician should not ignore the individual patient’s
medical history or the clinician’s assessment findings and clinical judgment. The challenges
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faced in ED’s are twofold, first how to recognize sepsis early and second, how to consistently
initiate the SSC EGDT as the standard treatment.
EGDT through implementation of interdisciplinary order sets or patient care bundles has
a positive impact on patient outcomes. Despite the knowledge that the utilization of these
bundles results in positive patient outcomes, there continues to be inconsistent implementation
and adherence to them worldwide (Weinert & Mann, 2008). According to Weinert and Mann,
(2008) there is a new arm of research emerging to look at these delay issues. This
implementation science, a new way to disseminate research is also called T2 or translational
research. It is a way for healthcare providers looking to help discover why there are delays in
getting research to the bedside and ways to get findings adopted into practice sooner.
Many barriers to implementation have been acknowledged. Weinert and Mann (2008)
identified that “guideline development and implementation strategies have occasionally
overshadowed the guidelines actual content” (pg. 463). Some additional reasons noted for the
underutilization of guidelines were the perceived lack of consideration for the individual
patient’s history and co-morbidities, and the possibility of excessive influence or financial stake
by authors or third party entities as the guidelines were being developed.
Related to ED adherence specifically, only 7% of emergency physicians from 30
academic tertiary care facilities reported that they used any EGDT when caring for their patients
(Carlbom and Rubenfeld 2007). These authors also concluded the results of their study were
consistent with other initiatives such as treatment for ventilator-associated pneumonia and hand
washing. Carlbom and Rubenfeld acknowledged that there are many challenges in getting
knowledge gained from research and applying it at the bedside.
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The literature clearly supports that the treatment of severe sepsis and septic shock should
be developed using the evidence based SSC EGDT guidelines. It also shows that the time it takes
to initiate EGDT guidelines after the clinician recognizes severe sepsis or septic shock greatly
influences the patient’s outcomes (Dellinger et al., 2008). For every hour delayed in the
administration of antibiotics in the severe sepsis patient the risk for a poor outcome increases by
7.6% (Zubert et al. 2010). Similarities of increased mortality secondary to the delay of time to
treatment can also be found in the trauma population. In trauma care, the golden hour is the time
immediately following injury, when survival is dependent on rapid assessments and appropriate
resuscitative interventions (Advanced Trauma Life Support, 2012).
The reluctance of healthcare providers to accept EGDT and change care delivery has
been compared to the same resistance seen when guidelines and protocols were developed to
care for the cardiovascular, stroke, and trauma populations (Huang et al., 2007). Some of the
barriers identified by administrators and clinicians are directly related to concerns that practice
changes can result in increased costs secondary to a lack of facility resources. ED overcrowding,
the absence of multidisciplinary education specific to sepsis patients, a general lack of
understanding of the mortality benefits of EGDT, and the absence of organizational leadership
support account for the lack of EGDT implementation.
The literature suggests that support for sepsis initiatives can be solicited from both
healthcare providers and the organizational leadership by sharing with them successful
implementation data from facilities that have already initiated established EBP protocols. The
positive impact on patient outcomes, the decrease in patient’s length of stays (LOS), and reduced
costs associated with the improved patient outcomes can and should be convincing rationale for
change. For example, it has been calculated that an ED that treats 91 severely septic or septic
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shock patients annually and consistently practices EGDT would realize an estimated savings of
approximately $788,606 a year (Haung et al., 2007). In addition, facilities that are already
centers for stroke, trauma, and cardiac patients would more than likely already have the
necessary multidisciplinary healthcare providers, technology and protocols in place to positively
impact the septic patient population without making extensive changes.

Program Implementation Efforts
In an effort to encourage adherence, a program called MUST (Multiple Urgent Sepsis
Therapies) was developed at the Beth Israel Deaconess Medical Center in Boston. It included
the rationale for each step of the protocol during its development. In addition, they creatively
adapted their trauma patient flow sheet used for nursing documentation to be available
specifically for septic patients (Jones, Shapiro & Roshon, 2007). As the format of this document
was already familiar to the staff and easy to use, the authors expected adherence would be high.
This same multidisciplinary group of clinicians also used a variety of educational techniques for
all the different disciplines prior to the protocol’s implementation. Post implementation, the team
monitored adherence to the protocol and communicated with the individual healthcare providers
after each septic patient was seen in the ED. The group’s goal was to develop an expectation that
there was accountability by all members of the team for the care they provided. Since its
implementation, this protocol has been established as the standard of care for the ED. Despite the
general acceptance of the new standard, this facility’s team admits that they continue to
encounter occasional challenges with compliance and hope that their consistent case reviews will
demonstrate that this program is being sustained. In order to sustain positive changes strategies
must include continued reviews and open communications with providers.
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In a study conducted at a large university based hospital in Madrid, researchers evaluated
their ED to determine if the physicians were using the sepsis bundle as implemented (de MiguelYanes et al., 2006). They found that during the two month long study the ED census totaled
31,238 patients. There were multiple missed septic patients and two patients who were thought to
have sepsis but were later determined to not be septic. In response to the results of this evaluation
the researchers concluded that the best way to improve the early recognition and treatment of
septic patients was to create a multidisciplinary collaborative team and develop a comprehensive
education program for the entire hospital staff. The strategy of multidisciplinary collaboration is
seen throughout the literature as an important component for development, implementation, and
sustaining positive changes.
In a comprehensive study by Nguyen et al. (2007) they describe a process of bundle
development followed by extensive sepsis education of the ED personnel and finally
implementation of the developed processes followed by an evaluation of the implementation
itself. Despite their extensive and intensive efforts the researchers noted that it took two years
post implementation to achieve a greater than 50% adherence to bundle use in the ED.
Several themes from the literature related to implementation of guidelines and protocols
have been identified. Multidisciplinary collaboration, not only between physicians and nurses,
but also different specialty areas within the facility, was a primary factor for success. This was
closely followed by an organized and systematic approach to the literature review, protocol
development, facility wide education and an evaluation program that included following up with
the individual healthcare providers post case review.
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Post Implementation Evaluations
Evaluating the impact of implementing any change in practice is an important component
of the change process. As a way to assist facilities and evaluate improvements the SSC
developed a performance improvement program and recruited 165 hospitals worldwide to
participate resulting in 15,022 patients being entered into their data base (Levy et al., 2010). The
purpose of this program was to determine the extent of practice changes and determine if use of
the SSC guidelines improved patient outcomes. Hospital participation in this program was
completely voluntary. Facilities were asked to enter data components related to the SSC
guidelines from the first six hours resuscitation bundle and the second 24 hour management
bundle into the secure data base. The data demonstrated overall good levels of compliance with
the first three measures in the six hour bundle. Those measures were obtaining serum lactate
levels, blood cultures prior to initial antibiotic administration, and administering appropriate
broad-spectrum antibiotic. Early recognition of sepsis by lactate measurement was done 86% of
the time. Obtaining blood cultures prior to antibiotic administration and initiation of appropriate
antibiotic therapy was documented 78% of the time. Interestingly, these three components are
most consistently performed in the ED. Although the outcomes of this performance improvement
process are not the result of formal scientific research these results demonstrated a decrease in
patient mortality when providers used the SSC guidelines. The authors did note, however, that
some of the decrease in mortality might also be attributed to patients being less critically ill when
enrolled as first thought.
Mikkelsen et al. (2010) looked specifically at the challenges one emergency department
faced during implementation and if EGDT was being consistently utilized for patients
experiencing severe sepsis and septic shock. The facility identified that utilization of the EGDT
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guidelines had, over the two year evaluation time frame, 2005 to 2007, decreased from 61% to
40%. Their results demonstrated that mortality rates for patients who had EGDT started but not
completed was at 36% while in patients who had EGDT initiated and completed mortality rate
was decreased to 30%. In addition, the authors noted an interesting discrepancy related to the use
of EGDT among the 33 ED physicians at this facility. When the treating ED physician was
female, EGDT was implemented 48.5% of the time compared to 62.4% of the time for their male
counterparts. The data also demonstrated that the younger physicians, with the least years of
experience in practice utilized EGDT guidelines more frequently than their older and more
experienced colleagues. The authors acknowledged their study’s interesting age and gender
findings related to implementation of EGDT and noted the need to investigate this further. In
addition, they suggested that EGDT protocol adherence might be improved if a “consultation
service” was created and became involved early in the patients care. The EDSSAPP audit
findings discussed earlier showed that SSA’s were only being activated 38.7% of the time; these
results are in line with facilities as found in the literature. Further research is needed to help
identify barriers to implementation of EGDT.
Looking back at the ORMC EDSSAPP process in light of information gained from this
comprehensive literature review, there is one component that stands out as most likely a
contributing factor to the perceived low numbers of SSA’s being activated- the gathering and
sharing of real time data with the healthcare team members.

Early Goal Directed Therapy/Safe and Cost Effective Care
Today’s healthcare environment requires facilities to provide safe and quality care while
continuously striving to maintain cost effectiveness. Shorr et al., (2007, pg 1257) cited that the
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“costs of sepsis are staggering and total tens of billions of dollars annually” and implementation
of evidenced-based sepsis protocols can result in substantial savings in both lives and costs of
care. Studies by Jones, Troyer and Kline (2011) and Talmor, Greenberg, Howell, Lisbon,
Novack and Shapiro (2008) looked at the cost effectiveness of implementing EGDT. In the
Talmor et al study (2008), the authors noted that once EGDT was initiated there was an increase
in both time and resources needed to care for septic patients. They also cited an increased LOS in
the intensive care unit (ICU) and associated care costs. The Jones et al. study (2011) had similar
results, concluding implementation of EGDT had indeed increased associated care costs. In both
studies, while the direct costs calculated for caring for severe sepsis and septic shock increased
after the implementation of EGDT, there were also corresponding increases in quality-adjusted
life years (QALYs) of the patients who survived. A QALY is defined as an estimate of how
many years of life that a reasonable person might gain secondary to medical treatment. There are
several factors considered when measuring the quality of life as related to the individual’s health.
These contributing factors include pain, and general ability to perform activities of daily living.
While the authors all agreed the indirect life year’s savings made up for the rise in direct care
costs for sepsis patients it is important to note that these were single center studies.
Lagu et al. (2011) used data collected by the Premier Healthcare Informatics in Charlotte
North Carolina, from 309 hospitals that treated 166,931 septic patients from 2004 to 2006. Their
goal was to determine if there was any association between the amount of money a hospital spent
on the care of septic patients and improved survival rates for these patients. The authors carefully
selected facilities and conducted complex statistical analyses to evaluate the outcomes. The
study results demonstrated care of the septic patient varies widely across the US and there was

29

no obvious association between increased hospital spending on costs of direct care for the septic
patient and improved patient survival rates.
Powell, Khare, Courtney and Feinglass (2010) also found results similar to Lagu et al.
(2011) related to the variety of care provided to sepsis patients in hospitals across the US. Data
for this study included 87,166 adult septic patients seen and treated in 551 US hospitals. The
results demonstrated ED’s experiencing higher volumes of septic patients were more likely to
have better-quality care for this vulnerable population. Clark and Normile (2007) identified that
holding admitted patients in the ED awaiting in house bed availability can contribute to increased
patient mortality. They also noted that mortality was increased on weekend shifts versus
weekday shifts. Despite the increased mortality for patients being held for admission Clark and
Normile’s data did show that septic patients who were seen and received initial treatment in the
ED did receive their antibiotics, on average, one hour sooner than patients directly admitted to an
inpatient bed.
The amount of literature available related to sepsis will continue to grow as the healthcare
community searches for ways to identify sepsis early and researchers look for the most effective
definitive treatment. In addition, it will not only be important for clinicians to stay abreast of the
latest related evidence but to find ways to implement the necessary changes to improve patient
outcomes and decrease mortality.
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CHAPTER THREE: METHODS
Severe sepsis is a significant threat to patients worldwide. While the previously reviewed
EDSSAPP audit snap-shot data demonstrated that this process had improved care for severely
septic patients in this organization’s ED, a more thorough evaluation of the process and its
associated outcomes was needed. Implementation of EBP requires practice change(s), as was
noted in the steps of the Iowa model. In addition, an analysis of the process changes and
associated data with a continued evaluation of the quality of care being delivered is necessary to
ensure improved patient outcomes. Another important step in this process is the dissemination of
results, communicating to the healthcare community is an important component as this
contributes to new knowledge and assists in demonstrating that translating research into practice
can improve care at the bedside.
The main goal of this study was to evaluate the impact of EDSSAPP, pre and post
implementation, on severe sepsis patients admitted via the ORMC ED. Specific components of
the process were selected for review based on their importance in contributing to positive patient
outcomes. Following the Iowa model process for implementation of evidence-based practice
recommendations, monitoring this process change and associated outcomes along with
disseminating the results is one way to contribute to sustaining the positive changes.

Research Aim
The primary aim of this study was to assess the outcomes of EDSSAPP on severe sepsis
patients admitted via the ORMC ED across three time cohorts on:
•

Alert activated versus no alert activated

•

Time to first antibiotic administration
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•

Total ED and hospital LOS

•

Mortality

Study Design
A retrospective review of data from the electronic medical record (EMR) was conducted
to gather the required data for the following cohorts:
1. Base line/time zero (T0): six months prior to the implementation of EDSSAPP; the
purpose of this data was for comparison with the other two time cohorts.
2. Time one (T1): the first six months following initial EDSSAPP implementation, to
determine the immediate impact of EDSSAPP.
3. Time two (T2): six months following reinstatement of the corporate sepsis committee;
these data were used for further comparisons to determine the impact of EDSSAPP.

Research Questions
All the data gathered for this study were analyzed to answer the following research
questions.
a. In ED patients with severe sepsis what was the effect of EDSSAPP on time to first
antibiotic administration at three time cohorts, T0, T1, and T2?
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP
on time to first antibiotic administration between time cohorts T1 and T2?
b. In ED patients without a severe sepsis alert activated what was the effect of
EDSSAPP on time to first antibiotic administration between time cohorts T0, T1, and
T2?
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c. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on time to first antibiotic administration within groups at time cohort T1?
d. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on time to first antibiotic administration within groups at time cohort T2?
2.1 In ED patients with severe sepsis, what was the effect of EDSSAPP on ED LOS across
three time cohorts T0, T1 and T2?
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP
on ED LOS between time cohortsT1 and T2?
b. In ED patients without a severe sepsis alert activated, what was the effect of
EDSSAPP on ED LOS between time cohorts T0, T1 and T2?
c. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on ED LOS within groups at time cohort T1?
d. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on ED LOS within groups at time cohort T2?
2.2 In ED patients with severe sepsis, what was the effect of EDSSAPP on hospital LOS
across three time cohorts T0, T1 and T2?
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP
on hospital LOS between time cohortsT1 and T2?
b. In ED patients without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS between time cohorts T0, T1 and T2?
c. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS within groups at time cohort T1?
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d. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS within groups at time cohort T2?
3. In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time
cohorts T0, T1 and T2?
4. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the
corporate sepsis committee on the number of severe sepsis alerts activated between time
cohorts T1 compared to T2?
a. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of
the corporate sepsis committee on the number of severe sepsis patients with a severe
sepsis alert activated between time cohorts T1 compared to T2?
b. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of
the corporate sepsis committee on the number of severe sepsis patients without a
severe sepsis alert activated between time cohorts T1 compared to T2?

Subject Sampling
The cohort data were obtained between 2009 and 2013 and a description of each cohort
can be seen in Table 3. Subjects included in T0 were a convenience sample of 22 patients
admitted to the hospital from the ORMC ED with any of the initial ICD 9 codes listed in Table 4
that did not have a SSA activated. Subjects without a SSA activated in T1(n = 26) and T2 (n =
21) were also a convenience sample consisting of all patients admitted to the hospital from the
ORMC ED with any of the initial ICD 9 codes listed in Table 3. All SSA activated patients from
T1 (n = 19) and T2 (n = 113) were obtained from the existing EDSSAPP log. The lists of
subjects with no SSA activated that were admitted for all three time cohorts from the ORMC ED
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were obtained following approval from the Orlando Health Nursing Research Council, the
ORMC and UCF IRB with waiver of consent, and application process to the Corporate Office of
Safety and Transformation, Clinical Analysis and Outcomes (CAO) at Orlando Health as
required by the organization’s policy.

Table 3: EDSSAPP patient cohorts
Baseline: Pre-EDSSAPP

Cohort 1: Post-EDSSAPP

Cohort 2: Post-Reinstatement of

Implementation

Implementation

Corporate Sepsis Committee

T0

T1

T2

4/1/09 to 9/28/09

9/29/09 to 3/31/10

8/14/12 to 2/14/13

Patients with Severe Sepsis

Patients with Severe Sepsis Alert

Patients with Severe Sepsis Alert

(n=22)

Activated (n=19)

Activated (n=113)

Severe sepsis/septic shock

Severe sepsis/septic shock patients for

Severe sepsis/septic shock patients for

patients meeting inclusion

the first six months post

six months post reinstatement of

criteria for the six months prior

implementation of EDSSAPP meeting

corporate Sepsis committee activity

to implementation of

inclusion criteria that had a severe

meeting inclusion criteria that had a

EDSSAPP.

sepsis alert paged.

severe sepsis alert paged.

Patients without Severe Sepsis Alert

Patients without Severe

Activated (n=26)

Sepsis Alert Activated (n=21)

Severe sepsis/septic shock patients for

Severe sepsis/septic shock patients for

the first six months post

six months post reinstatement of

implementation of EDSSAPP who met

corporate Sepsis committee activity

inclusion criteria and did NOT have a

meeting inclusion criteria and did NOT

severe sepsis alert paged.

have a severe sepsis alert paged.

Inclusion criteria consist of all ORMC ED patients who were:
•

18 years or older

•

Admitted to the hospital through this ED during the assigned time cohorts

•

Diagnosed with any of the ICD-9 codes listed in Table 4 with or without a SSA activated
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Exclusion Criteria consists of all ORMC ED patients who were:
•

Younger than 18 years

•

Admitted to the hospital through the ORMC ED without an initial ICD-9 code as listed in
Table 4

•

Expired in the ED, or were not admitted to this facility

•

All patients that were transferred to a nursing home, skilled nursing facility, or hospice
outside the Orlando Health system from the ED

Setting
The Orlando Regional Medical Center (ORMC) ED is a 58 bed, state-certified, level one
trauma center. The average daily census is 200 patients with 30% to 37% of these patients being
admitted to the hospital. ORMC is a Joint Commission-accredited facility, and the ED is staffed
by board-certified emergency physicians and emergency medicine residents. The ED’s nursing
staff has a wide range of experience from one year to thirty years with approximately 20% of the
nursing staff holding the national certification- Certified Emergency Nurse (CEN). In addition,
the ED is staffed by state certified paramedics, licensed clinical social workers, licensed
respiratory therapists, radiology technicians, certified phlebotomists and advanced clinical
technicians. Standardized evidence-based guidelines are currently implemented for the trauma,
cardiac and stroke patient populations.

Protection of Human Subjects
As this was a retrospective EMR review, the only direct risk to subjects selected for this
study is the possible breach of confidentiality. In addition, there are no direct or indirect benefits
to these subjects. This study was presented to the Nursing Research Council and following their
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approval was submitted to the Institutional Review Boards at both the University of Central
Florida and Orlando Health, approval letters are provided in Appendices G, H, I. Consent was
obtained from Orlando Health to use the EDSSAPP process for this study (Appendix J).

Confidentiality
The data protection plan for this study includes ensuring that all data were de-identified,
entered into the secured electronic spread sheets and kept on a password protected computer and
encrypted flash drive locked in the Clinical Nurse Specialist’s office.

Data Collection
Initial electronic lists of ED patients hospitalized for the three cohorts were obtained from
the hospital’s CAO Department. Once these lists were screened for inclusion criteria, the specific
approved variables were collected through a comprehensive retrospective EMR review by the
study team. The study data obtained included the approved descriptive, independent, and
dependent variables for all the groups in each of the three time cohorts and can be seen in Table
4 along with the statistical test planned to analyze the data. A sample of the spreadsheet that was
used for data entry can be seen in Appendix K.

Table 4: Descriptive variables and data analysis plan
Descriptive Variables
Variable
Day of the week

Level of
Measurement
Nominal

Coding
1= Monday
2= Tuesday
3= Wednesday
4= Thursday
5= Friday
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Statistical Test
Frequencies, percent

Descriptive Variables
Variable

Level of
Measurement

Coding

Statistical Test

6= Saturday
7= Sunday
Time of arrival

Scale

Clocked military time

Will be used to calculate
time to initial antibiotic

Mode of arrival

Nominal

1= Private car
2= EMS

Frequencies, percent

Gender

Nominal

0= Male
1= Female

Frequencies, percent

Age

Scale

Age in years.

Frequencies, percent;
Mean, Mode, Median,
Standard Deviation

Race

Nominal

1= Caucasian
2= Hispanic
3= African American
4= Asian
5= Other

Frequencies, percent

ICD-9 codes

Nominal

1. 38.0 Strep sepsis
2. 38.11 MRSA Sepsis
3. 38.12 Methicillin-resistant
Staphylococcus aureus (MRSA)
septicemia
4.38.19 Staphylococci
septicemia NEC
5. 38.40 Gram-neg septicemia
(NOS)
6. 38.42 Ecoli sepsis
7. 38.43 Pseudomonas
septicemia
8. 38.44 Serratia septicemia
9. 38.49 Gram-neg septicemia
NEC
10. 38.9 Septicemia NOS
11. 670.04 Major puerp
infection NOS-p/p
12. 728.86 Necrotizing Fasciitis
13. 785.52 Septic Shock
14. 995.91 Sepsis
15. 995.92 Severe Sepsis
16. 999.31 Infection due to
central venous catheter

Frequencies, percent

Presenting complaint

Nominal

Open category

Frequencies, percent
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Descriptive Variables
Variable

Level of
Measurement

Coding

Statistical Test

Initial ED lactate level

Scale

Number
mEq/L

Frequencies, percent;
Mean, Mode, Median,
Standard Deviation

Initial ED lactate serum source

Nominal

1= Venous
2= Arterial

Frequencies, percent

Initial ED White Blood Cell
Count

Scale

Number (cells per mcL)

Frequencies, percent;
Mean, Mode, Median,
Percent, Standard
Deviation

Time from order to First
Antibiotic Administration

Scale

Calculated from the time of
EDMD order to the time of
EDRN initiation of
administration.

Frequencies, percent;
Mean, Mode, Median,
Percent, Standard
Deviation

Time of discharge from ED

Scale

Military Time

Used to calculate ED
LOS (minutes?)

ED LOS

Scale

Calculated from the time of
arrival to the ED to the time
departed from the ED to inpatient bed.

Frequencies, percent;
Mean, Mode, Median,
Percent, Standard
Deviation

Hospital LOS

Scale

Time of arrival to ED to time of
discharge from the hospital or
death.

Frequencies, percent;
Mean, Mode, Median,
Percent, Standard
Deviation

Mortality

Nominal

1=Discharged
2=Expired

Frequencies, percent

Number of Severe Sepsis
patients admitted to the hospital
from the ED during the noted
time frames

Scale

Number of severe sepsis patients
admitted from the ED.

Frequencies, percent;
Mean, Mode, Median,
Percent, Standard
Deviation

The ICD-9 codes were used as a part of the inclusion criteria with 16 initial codes related
to sepsis approved for this study can be seen in Table 5. At the beginning of data gathering the PI
and Co-PI elected to gather only one initial admission and principal ICD-9 code on each of the
EMR’s as these patients had multiple ICD-9 codes, some had as many as 20 per patient record.
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Table 5: Initial ICD-9 codes
ICD-9 Code

Definition

38.0

Strep sepsis

38.11

MRSA Sepsis

38.12

Methicillin-resistant Staphylococcus aureus (MRSA) septicemia

38.19

Staphylococci septicemia NEC

38.40

Gram-neg septicemia (NOS)

38.42

Ecoli sepsis

38.43

Pseudomonas septicemia

38.44

Serratia septicemia

38.49

Gram-neg septicemia NEC

38.9

Septicemia NOS

670.04

Major puerp infection NOS-p/p

728.86

Necrotizing Fasciitis

785.52

Septic Shock

995.91

Sepsis

995.92

Severe Sepsis

999.31

Infection due to central venous catheter

The most complex variables to measure were the patient’s initial/presenting complaints.
The Principal Investigator (PI) and statistician collaborated to categorize this variable in order to
have a meaningful way to calculate the data. The patients initial/presenting complaints were
grouped by systems and a summary of these groupings and their associated percentage per cohort
are listed in Table 9 in Chapter 4.

Inter-Rater Reliability
Inter rater reliability was established by the PI prior to any data gathering by the research
team. As a part of the CNS’s practice, EMR’s are regularly reviewed for audits and process
improvement projects; this activity supports CNS as the PI’s expertise in EMR review. The CNS
chose five severe sepsis charts and gathered the required data. Next, the team of co-investigator
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and sub-investigators were given the same five charts independently to abstract the required data
points. The inter-rater reliability data sheets were reviewed and scored for accuracy against the
CNS completed data sheet. A 100% matching was obtained and accurate inter-rater reliability
achieved. None of the investigators failed to meet the required standard and no remediation or
reevaluation was needed.

Statistics and Data Analysis
Data were entered into the approved SPSS (v 21) spread sheets followed by a thorough
review to ensure accuracy by the PI and statistician. Descriptive and inferential statistics were
run as appropriate to the research questions as seen in Table 6. The data related to the ED and
hospital LOS were not normally distributed, therefore non-parametric statistics were run.
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Table 6: Data analysis plan by research questions
Research Questions

Variable

Level of

Coding

Statistical Test

Measurement
RQ 1. In ED patients with severe sepsis what was the effect of EDSSAPP on time to first antibiotic administration at three time cohorts, T0, T1, and T2?
a. In ED patients with a SSA activated, what

IV: EDSSAPP

Nominal

was the effect of EDSSAPP on time to first

0=No

Chi Square

1=Yes

antibiotic administration between time cohorts
T1 and T2?

DV: Total antibiotic time (from

Nominal

1= <60 minutes
2= > 60 minutes

initial antibiotic order to time of
antibiotic administration)
b. In ED patients without a SSA activated,

IV: EDSSAPP

Nominal

what was the effect of EDSSAPP on time to

0=No

Chi Square

1=Yes

first antibiotic administration between time
cohorts T0, T1, and T2?

DV: Total antibiotic time (from

Nominal

initial antibiotic order to time of

1= <60 minutes
2= > 60 minutes

antibiotic administration)
c. In ED patients with and without a SSA

IV: EDSSAPP

Nominal

activated what was the effect of EDSSAPP on

0=No

Chi Square

1=Yes

time to first antibiotic administration within
time cohort T1?

DV: Total antibiotic time (from

Nominal

initial antibiotic order to time of

1= <60 minutes
2= > 60 minutes

antibiotic administration)
d. In ED patients with and without a SSA

IV: EDSSAPP

Nominal

activated what was the effect of EDSSAPP on

0=No
1=Yes

time to first antibiotic administration within
time cohort T2?

DV: Total antibiotic time (from
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Nominal

1= < 60 minutes

Chi Square

Research Questions

Variable

Level of

Coding

Statistical Test

Measurement
initial antibiotic order to time of

2= > 60 minutes

antibiotic administration)
RQ 2.1. In ED patients with severe sepsis what was the effect of EDSSAPP on ED LOS across three time cohorts T0, T1 and T2?
a. In ED patients with a SSA activated what

IV: EDSSAPP

Nominal

was the effect of EDSSAPP on ED LOS

0=No

Mann-Whitney U

1=Yes

between time cohorts T1 and T2?

b. In ED patients without a SSA activated

DV: ED LOS

Ratio

Number of minutes

IV: EDSSAPP

Nominal

0=No

what was the effect of EDSSAPP on ED LOS
between time cohorts T0, T1 and T2?

Kruskal Wallis test

1=Yes
DV: ED LOS

Ratio
Number of minutes

c. In ED patients with and without a SSA

IV: EDSSAPP

Nominal

activated, what was the effect of EDSSAPP on

0=No

Mann-Whitney U

1=Yes

ED LOS within time cohorts at T1?

d. In ED patients with and without a SSA

DV: ED LOS

Ratio

Number of minutes

IV: EDSSAPP

Nominal

0=No

activated, what was the effect of EDSSAPP on

Mann-Whitney U

1=Yes

ED LOS within time cohorts at T2?
DV: ED LOS

Ratio

Number of minutes

RQ 2.2. In ED patients with severe sepsis what was the effect of EDSSAPP on hospital LOS across three time cohorts T0, T1 and T2?
a. In ED patients with a SSA activated what

IV: EDSSAPP

Nominal

was the effect of EDSSAPP on hospital LOS

0=No
1=Yes

between time cohorts T1 and T2?
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Mann-Whitney U

Research Questions

Variable

Level of

Coding

Statistical Test

Measurement

b. In ED patients without a SSA activated

DV: hospital LOS

Ratio

Number of days

IV: EDSSAPP

Nominal

0=No

what was the effect of EDSSAPP on hospital
LOS between time cohorts T0, T1 and T2?

Kruskal Wallis test

1=Yes
DV: hospital LOS

Ratio
Number of days

c. In ED patients with and without a SSA

IV: EDSSAPP

Nominal

activated, what was the effect of EDSSAPP on

0=No

Mann-Whitney U

1=Yes

hospital LOS within time cohorts at T1?

d. In ED patients with and without a SSA

DV: hospital LOS

Ratio

Number of days

IV: EDSSAPP

Nominal

0=No

activated, what was the effect of EDSSAPP on

Mann-Whitney U

1=Yes

hospital LOS within time cohorts at T2?
DV: hospital LOS

Ratio

Number of days

RQ 3. In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time cohorts T0, T1 and T2?
RQ 3. In ED severe sepsis patients, what was

IV: EDSSAPP

Nominal

the effect of EDSSAPP on mortality between

0= No

Chi Square

1= Yes

time cohorts T0, T1 and T2?
DV: Mortality

Nominal

0=No
1= Yes

RQ 4. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the corporate sepsis committee on the number of severe sepsis
patients with and without a severe sepsis alert activated between time cohorts T1 compared to T2?
RQ 4. In ED severe sepsis patients, what was

IV: EDSSAPP with reactivation of

the effect of EDSSAPP with reactivation of the

corporate sepsis committee

corporate sepsis committee on the number of
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Nominal

0= No
1= Yes

Chi Square

Research Questions

Variable

Level of

Coding

Statistical Test

Measurement
severe sepsis patients with and without a

DV: Number of SSAs and SSNAs

severe sepsis alert activated between time

Nominal

cohorts T1 compared to T2?

0= No
1=Yes

a. In ED severe sepsis patients, what was the

IV: EDSSAPP with reactivation of

effect of EDSSAPP with reactivation of the

corporate sepsis committee

Nominal

0= No

Chi Square

1= Yes

corporate sepsis committee on the number of
severe sepsis patients with a severe sepsis alert

DV: Number of SSAs

activated between time cohorts T1 compared

Nominal

to T2?

0= No
1=Yes

b. In ED severe sepsis patients, what was the

IV: EDSSAPP with reactivation of

effect of EDSSAPP with reactivation of the

corporate sepsis committee

Nominal

0= No
1= Yes

corporate sepsis committee on the number of
severe sepsis patients without a severe sepsis

DV: Number of S0SAs

alert activated between time cohorts T1

Nominal

compared to T2?

0= No
1=Yes
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Chi Square

CHAPTER FOUR: RESULTS
In this chapter the results of the data analyses are presented followed by the findings as
related to each of the study questions. Data were examined for missing values, outliers and
normality as appropriate. Descriptive statistics, frequencies, Chi Square, Mann- Whitney U, and
Kruskal Wallis tests were used for this study. Data were analyzed using the Statistical Package
for the Social Sciences (SPSS) version 21.
Raw data were obtained following the approved process and the data were received in an
Excel spread sheet via secure hospital email. A total of 2,330 patients were included in the initial
raw data requested. Once the data were screened using the inclusion and exclusion criteria, a
total of 201 patients were included. Table 7 is a summary of the total number of patients that
populated each of the study cohorts. A table of the entire EDSSAPP demographic data is shown
in Appendix L.

Table 7: Sample size per time cohort
Cohort
No Alert Activated
Alert Activated
Total
TIME 0
22
0
22
TIME 1
26
19
45
TIME 2
21
113
134
Total
69
132
201
Time 0 = Pre EDSSAPP, Time 1 = First 6 months post EDSSAPP implementation, Time 2 = EDSSAPP following
the reactivation of corporate sepsis committee.

Sample Characteristics
The demographic data were for each of the cohorts individually and for the total study
population as a whole. Demographic data and baseline characteristics for this study are
summarized in Table 8.
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Table 8: EDSSAPP demographic data
Time Cohorts
All Time

Time 0

Cohorts

No Alert

Alert

No Alert

Alert

No Alert

(n = 22)

(n = 19)

(n = 26)

(n = 113)

(n = 21)

201 (100%)
Size

Time 1

Time 2

22

19

26

113

21

(10.94%)

(9.45%)

(12.93%)

(56.21%)

(10.44%)

59.86

62.37

53.62

64.95

62.43

(18.31)

(20.78)

(21.53)

(16.66)

(19.82)

Age Mean
(sd)

62.42 (18.47)

Median

64.0

63.5

68.0

52.0

67.0

62.0

(range)

(19-102)

(23-90)

(23-93)

(19-88)

(19-95)

(29-102)

Male

103 (51.2)

9 (40.9)

14 (73.7)

17 (65.4)

57 (50.4)

6 (28.6)

Female

98 (48.8)

13 (59.1)

5 (26.3)

9 (34.6)

56 (49.6)

15 (71.4)

Gender Mean

Characteristic

(%)

Race Mean
(%)

10 (47.6)

Caucasian

116 (57.7)

14 (63.6)

13 (68.4)

14 (53.8)

65 (57.5)

6 (28.6)

Black

60 (29.9)

4 (18.2)

6 (31.6)

8 (30.8)

36 (31.9)

4 (19.0)

Hispanic

21 (10.4)

3 (13.6)

0 (0.0)

4 (15.4)

10 (8.8)

1 (4.8)

Asian

4 ( 2.0)

1 (4.5)

0 (0.0)

0 (0.0)

2 (1.8)

Alert

132 (65.7)

0 (0.0)

19 (100)

0 (0.0)

113 (100)

0 (0.0)

No Alert

69 (34.4)

22 (100)

0 (0.0)

26 (100)

0 (0.0)

21 (100)

Alert Status
Mean
(%)

Of the 201 patients, the mean age for the total sample was 62.42 years (range 19-102
years, SD 18.47 years). Most were white (57.7%) with an even gender distribution of male
(51.2%) and female (48.8%). The majority had a severe sepsis alert activated (65.7%).
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Presenting/Chief Complaint
The initial presenting/chief complaints varied widely as the EMR documentation of the
complaints were based on what the patient or family stated to the ED staff on arrival. To
organize these complaints in a systematic way for statistical analysis the study’s PI and
statistician collaborated to group the presenting or chief complaints by placing them into medical
system categories. A non-parametric test (Kruskal Wallis) was conducted comparing the ED
chief complaints in each category across the three time cohorts. The only chief complaint
category that was statistically significant was skin/wounds with a p value of .001, despite the
total number of patients in this category being small (n= 9). The list of the system categories and
associated complaints, with numbers, percentages and p values are listed in Table 9.

Table 9: Initial/presenting complaint summary
System
Metabolic

Examples of Conditions
Hypoglycemia

Total

T0

T1

T2

p values

n (%)

n (%)

n (%)

n (%)

56 (27.9)

4 (18.2)

10 (22.2)

42(31.3)

.43

51 (25.4)

8 (36.4)

12 (26.6)

31(23.1)

.40

31 (15.4)

5 (22.7)

7(15.5)

19(14.2)

.35

Fever/chills
Electrolyte imbalance
Sepsis
Hyperglycemia
Flu like symptoms
Septic shock
Neurologic

Altered mental status
Un-responsive
Seizures
Near syncope
Syncope

Respiratory

Pneumonia
Shortness of breath
Respiratory distress
Difficulty breathing
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System

Examples of Conditions

Total

T0

T1

T2

n (%)

n (%)

n (%)

n (%)

p values

Pleural
Effusion
Hemoptysis
Gastro-

Abdominal pain

intestinal

Displaced peg tube

18 (9.0)

1 (4.5)

3 (6.6)

14(10.4)

.15

12 (6.0)

3 (13.6)

2 (4.4)

7 (5.2)

.50

9 (4.5)

0 (0.0)

6 (13.3)

3 (2.2)

.001

3 (1.5)

0 (0.0)

0 (0.0)

3 (2.2)

.89

21 (10.4)

1 (4.5)

5 (11.1)

15(11.2)

.35

Abdominal abscess
Nausea and vomiting
Diarrhea
Rectal bleeding
Liver failure
Small bowel obstruction
Vomiting and diarrhea
Partial small bowel
obstruction
Rectal pain
Cardiac

Hypo-tension
Chest pain
Supra- ventricular tachycardia
STEMI alert

Skin-Wounds

Abscess
Multiple wounds
Gangrene
Decubitus ulcer
Infected dialysis catheter
wound

Genital-

Urinary tract infection

urinary

Need dialysis
Hematuria
Urinary retention
Dysuria

Other

Problem with central venous
line
Pain
Weakness
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System

Examples of Conditions

Total

T0

T1

T2

n (%)

n (%)

n (%)

n (%)

p values

Displaced tube
Pulled muscle
General illness
Failure to thrive

Research Questions
Research Question 1: Antibiotic Administration
In ED patients with severe sepsis what was the effect of EDSSAPP on time to first antibiotic
administration at three time cohorts T0, T1 and T2?
Antibiotic administration times were placed into two groups: those < 60 minutes and
those > 60 minutes for statistical analysis based on the EDSSAPP antibiotic administration time
requirement. A Chi-Square test was conducted comparing antibiotic time (< 60 minutes versus >
60 minutes) in patients with severe sepsis (with and without a severe sepsis alert activated) in
time cohorts T0, T1, and T2. No statistically significant differences in time of antibiotic
administration was found between T0, T1, and T2 (p = .38), results are listed in Table 10.
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Table 10: ED antibiotic administration times by time cohorts and groups
Characteristics

X2
p value

Time Cohorts
T0
n = 22

T1
n = 45

T2
n = 134

n (%)

n (%)

n (%)

Yes

18 (81.8)

32 (71.1)

108 (80.6)

No

4 (18.2)

13 (28.9)

26 (19.4)

Groups:
Severe Sepsis Alert

No Alert
n = 22

Alert
n = 19

No Alert
n = 26

Alert
n = 113

No Alert
n = 21

Antibiotic Time
< 60 minutes

n (%)

n (%)

n (%)

n (%)

n (%)

Yes

18 (81.8)

-

19 (73.1)

-

18 (85.7)

No

4 (18.2)

-

7 (26.9)

-

3 (14.3)

Yes

-

13 (68.4)

-

90 (79.6)

-

No

-

6 (31.6)

-

23 (20.4)

-

Yes

-

13(68.4)

19 (73.1)

-

-

No

-

6 (31.6)

7 (26.9)

-

-

Yes

-

-

-

90 (79.6)

18 (85.7)

No

-

-

-

23 (20.4)

3 (14.3)

All Patients
Antibiotic Time
< 60 minutes

.38

p value

.74
.52
.35
.51

Research Question 2.1: ED Length of Stay
In ED patients with severe sepsis, what was the effect of EDSSAPP on ED LOS across three time
cohorts T0, T1 and T2?
A Kruskal Wallis test was conducted comparing the ED LOS of patients with severe
sepsis at the three different time cohorts. Although the ED LOS was shorter in T1, there was no
significant difference in ED LOS across the three time cohorts (p = .14).
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP on
ED LOS between time cohorts T1 and T2?
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A Mann-Whitney U test was conducted comparing the mean ED LOS in patients with a
severe sepsis alert activated in T1 versus T2. There was a statistically significant lower ED LOS
in patients with a severe sepsis alert activated in cohort T1 (365.32 minutes) compared to T2
(422.88 minutes) resulting in a p value of .05.
b. In ED patients without a severe sepsis alert activated, what was the effect of EDSSAPP
on ED LOS between time cohorts T0, T1 and T2?
A Kruskal Wallis test was conducted comparing the ED LOS of patients without a severe
sepsis alert activated at the three different time cohorts. Although the ED LOS was shorter for
patients without a severe sepsis alert activated in T1, there was no overall significant difference
in ED LOS across the three time cohorts (p = .44).
c. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on ED LOS at time cohort T1?
A Mann-Whitney U test was conducted comparing the ED LOS in patients with and
without a severe sepsis alert activated in T1. Although there was a shorter ED LOS for patients
that had a SSA activated there was no significant difference found between the groups (p=.32).
d. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on ED LOS at time cohort T2?
A Mann-Whitney U test was conducted comparing the mean ED LOS in patients with
and without severe sepsis alert in T2. Although there was a shorter ED LOS for patients that had
a SSA activated there was no significant difference was found between groups (p=.37).
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Research Question 2.2: Hospital Length of Stay
In ED patients with severe sepsis, what was the effect of EDSSAPP on hospital LOS across three
time cohorts T0, T1 and T2?
A series of non-parametric tests (Mann - Whitney U and Kruskal Wallis) were conducted
comparing the hospital LOS in patients with and without a SSA activated in time cohorts T0, T1,
and T2. The following changes occurred but were not statistically significant: overall the hospital
LOS was shorter in T1 (mean rank 94.1) compared to T0 (mean rank 97.8) and T2 (mean rank
103.84) with a p value of .60.
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP
on hospital LOS between time cohorts T1 and T2?
A Mann-Whitney U test was conducted comparing mean hospital LOS in patients with a
severe sepsis alert activated in T1 versus T2. There was no significant difference in hospital LOS
in patients with a severe sepsis alert activated in cohorts T1 compared to T2 (p = .51).
b. In ED patients without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS between time cohorts T0, T1 and T2?
A Kruskal Wallis test was conducted comparing the hospital LOS of patients without a
severe sepsis alert activated at the three different time cohorts. Although the hospital LOS was
shorter in T1, there was no overall significant difference in hospital LOS across the three time
cohorts (p = .94).
c. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS at time cohort T1?

53

A Mann-Whitney U test was conducted comparing hospital LOS in patients with and
without a severe sepsis alert activated in T1. There was no significant difference in hospital LOS
(p = .75).
d. In ED patients with and without a severe sepsis alert activated, what was the effect of
EDSSAPP on hospital LOS at time cohort T2?
A Mann-Whitney U test was conducted comparing hospital LOS in patients with and
without a severe sepsis alert activated in T2. There was no significant difference in hospital LOS
(p = .54).

Table 11: ED and hospital length of stay by time cohorts and groups
Time Cohorts
Characteristics
ED Length of Stay a
(range in minutes)
ED Length of Stay b
(range in minutes)
Hospital Length of Stay a
(range in days)
Hospital Length of Stay b
(range in days)
Sepsis Alert Groups
ED Length of Stay a
(range in minutes)
Hospital Length of Stay a
(range in days)
ED Length of Stay b
(range in minutes)
Hospital Length of Stay b
(range in days)
ED Length of Stay b
(range in minutes)
Hospital Length of Stay b
(range in days)
ED Length of Stay b
(range in minutes)
Hospital Length of Stay b
(range in days)
a
Kruskall Wallis; bMann-Whitney U

p value

T0

T1

T2

442.18
(163-881)

394.10
(67-807)
394.10
(67-807)
9.22
(1-43)
9.22
(1-43)
Alert
No Alert

533.00
(54-1772)
533.00
(54-1772)
9.52
(1-91)
9.52
(1-91)
Alert
No Alert

11.95
(1-60)

Alert

No Alert

-

(163-881)

442.18

422.88
-

(67-807)

11.95

578.19
-

(173-1442)

9.00

.14
.05
.60
.33
.44

8.57

-

(1-60)

365.32

(1-43)

487.81

(1-21)

.94

-

-

(127-793)

-

(54-1772)

-

.05

9.00
-

-

422.88

(1-91)

-

.51

365.32
(127-793)

(67-807)

-

-

.32

9.00

9.00

(1-43)

-

10.48

-

-

(1-43)

(1-43)

487.81

578.19

.75

-

-

-

-

(54-1772)

(173-1442)

.37

-

-

-

-

54

10.48

8.57

(1-91)

(1-21)

.54

Research Question 3: Mortality
In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time cohorts
T0, T1 and T2?
A Chi Square test was conducted comparing mortality (Yes versus No) in severe sepsis
patients (with and without a severe sepsis alert activated) between time cohorts T1 and T2, in
comparison to T0. A statistically significant decrease in mortality (p = .04) was found in T2, T0
(n=5, 22%), T1 (n=15, 33%) T2 (n=22, 16%). (Table 12).

Research Question 4: Activation of Severe Sepsis Alert.
a. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the
corporate sepsis committee on the number of severe sepsis patients with a severe sepsis alert
activated between time cohorts T1 compared to T2?
b. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the
corporate sepsis committee on the number of severe sepsis patients without a severe sepsis
alert activated between time cohorts T1 compared to T2?
A Chi Square test was conducted comparing the number of severe sepsis patients with
and without a severe sepsis alert activated (Yes versus No) between time cohorts T1 and T2. A
statistically significant increase in the number of severe sepsis alerts activated was found
between T1 (n=19) and T2 (n=113) resulting in a p value of .001). Although no statistically
significant differences were found in number of severe sepsis patients that did not have a SSA
activated between T1 (n=26) and T2 (n=21) with a p value of .06 this should be considered a
clinical significance with more severe sepsis patients were recognized, alerted and treated.
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Table 12: ED severe sepsis alerts activated and mortality by time cohorts
Characteristics

Time Cohorts
T0

T1

T2

n = 22

n = 45

n = 134

n (%)

n (%)

n (%)

Yes

-

19 (42.2)

113 (84.3)

No

-

26 (57.8)

21 (15.6)

Yes

5 (22.72)

15 (33.33)

22 (16.42)

No

17 (77.27)

30 (66.67)

112 (83.6)

All Patients
Sepsis Alert Activated

p value

.001

Mortality
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.04

CHAPTER FIVE: DISCUSSION
This study evaluated the impact of EDSSAPP implementation on antibiotic
administration times, length of stay (ED and Hospital), and mortality over two time cohorts (T1,
T2) as compared to pre-implementation (T0). In addition, this study evaluated the impact of the
corporate sepsis committee activity on the number of severe sepsis alerts activated versus not
activated were compared during time cohorts T1 and T2.
Study findings provide preliminary support for implementation of EDSSAPP with the
additional corporate sepsis committee activity on improving outcomes of ED patients with severe
sepsis. Additional research is needed to evaluate the impact of other external factors that may
influence these outcomes, such as patient characteristics, competing patient care priorities and
the overall ED personnel’s attitudes, perception and knowledge of the EDSSAPP process and
goals.
Utilization of evidence-based guidelines to address severe sepsis in the ED is an ongoing
challenge. Barriers to implementation of and adherence to evidence-based guidelines or
protocols include physician concerns related to the perceived lack of consideration for
individualization of patient treatment and the potential influence of outside third parties, such as
pharmaceutical companies, on research outcomes. The reluctance to accept standardized sepsis
guidelines are similar to the challenges experienced when other standardized guidelines for
diseases, such as acute coronary syndrome, stroke, and trauma, were implemented (Huang et al.,
2007). In a 2013 systematic literature review of adherence to guidelines and protocols in the prehospital and emergency care settings Ebben et. al. (2013) noted that adherence to either national
or international guidelines ranged from 7.8% to 95%. No one single reason was identified for
this issue, rather it was recommended that in order to ensure improvements in quality patient care
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via the use of evidence-based guidelines and protocols strategies must be developed to increase
healthcare providers’ adherence. As with previous guideline acceptance, more time to gather and
review data may be needed to demonstrate positive patient outcomes from guideline utilization
in order to have a universal acceptance of standardized sepsis guidelines in the ED. In addition,
the local EMS agencies have instituted their own Sepsis Alert process using the SSC criteria;
increased collaboration with our pre-hospital partners related to their sepsis alert process is a
good first step to improve coordination of care across the continuum.

Activation of Severe Sepsis Alert
The most significant finding of this study was the increased number ED patients who had
severe sepsis alerts activated in time cohort T2. The number of severe sepsis alerts activated in
T2 (n=113) compared to T1 (n=19) was significantly increased and was most likely the result of
influence upon ED personnel by the re-activation of the corporate severe sepsis committee.
Literature world-wide has consistently noted that despite the evidence showing improved patient
outcomes following the use of the SSC patient care bundles there continues to be inconsistent
utilization (Weinert & Mann, 2008). The re-activation of the corporate sepsis committee in T2
(8/2012 – 2/2013) resulted in focused directed activities including physician to physician
communications and CNS clinical rounding in an effort to increase the ED personnel’s
awareness of severe sepsis and adherence to EDSSAPP. Though not statistically significant, the
number of ED severe sepsis patients that did not have an alert activated decreased from T1
(n=26) to T2 (n=21). In a study by Nguyen et.al. (2007) they noted that despite their intensive
and extensive efforts to educate personnel and increase utilization of their severe sepsis bundles
it took over two years to finally reach greater than 50% compliance with their sepsis bundle use.
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This study was conducted over 18 months and as seen in the literature it takes time to implement
process changes and consistent efforts to sustain the changes. The CNS role is uniquely designed
to both lead evidence-based change and support collaboration with multidisciplinary personnel to
sustain the changes.

Mortality
Another important finding was that mortality significantly decreased at T2 (16.4%)
compared to T0 (22.7%) and T1 (33%). The re-activation of the corporate sepsis committee and
active involvement of the CNS with rounding and on-going continuous efforts to increase staff
awareness of EDSSAPP may have influenced reducing mortality compared to the EDSSAPP
intervention alone. However, despite the reduction of mortality in T2 compared to T0 and T1, the
number of patients who received antibiotics in less than 60 minutes did not increase across the
three time cohorts. T0 had 82% receive antibiotics within 60 minutes while T1 had 71% and T2
had 81%. This is a curious finding as the literature has shown that delays in antibiotic
administration can contribute to increased mortality for severe sepsis patients (Zubert et al.
2010). It is possible that the EDSSAPP order set components were being implemented on all ED
patients with severe sepsis, even when there was no alert being activated on the patient. While
individual order set components initiations were not collected for this study, this could be
contributing to the lower mortality rates. Other potential contributing factors to consider are
possible decreased ED patient volumes, allowing the staff more time to care for each patient,
decreased patient acuities, and increased in-patient bed availability resulting in the ED not
holding patients for extended times.
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Hospital and ED LOS
The hospital length of stay was significantly increased by almost 1.5 days between those
patients with a severe sepsis alert activated in T1 (9.00 days) compared to time T2 (10.48 days).
Also, there was no significant decrease in the ED LOS across time cohorts and between groups
of patients who had a severe sepsis alert activated versus no alert activated. However, there was a
1 hour and 28 minute lower in ED LOS in patients who had a severe sepsis alert activated in T1
compared to T0. Also, there was a 1 hour and 52 minutes lower in ED LOS between patients
who had a severe sepsis alert activated compared to those who had no alert activated in T2. One
potential contributing factor to either the increased or decreased ED LOS when a SSA is called is
the role of the hospital administrative supervisors (AS). The AS’s receive the notification when a
SSA is called. This allows them to evaluate all the patients currently waiting to be assigned inpatient beds. Using the information related to each patient’s acuity level could potentially move
the SSA patient to the top of the list thereby decreasing their ED LOS. The AS process and it’s
contribution to ED LOS was not evaluated as a part of this study.
There are many unknown external factors that may have contributed to the increased
hospital LOS in T2 that were not evaluated for this study such as, patient comorbidities, hospital
acquired complications (falls, pressure ulcers, catheter associated urinary tract infections
[CAUTI], central line associated blood stream infections [CLABSI], discharge placement,
etc.).The Institute of Medicine brought attention to the need to improve patient care and safety
by reducing/preventing medical errors in their 2000 To Err is Human report. This report
estimates that the total costs of these errors include longer hospital stays and related medical
treatment, loss of life, productivity and disability is potentially greater than $29 billion every
year in the US (IOM Report, 2000).
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ED’s are challenged to rapidly identify severe sepsis patients as this illness creates a wide
variety of symptoms which can mimic many other serious medical conditions. This makes the
assessment process a complex endeavor while searching for a definitive diagnosis and initiating
the appropriate treatment an ongoing challenge (Raghavan & Marik, 2006). The complexity of
presenting signs and symptoms masking the actual cause of the patient’s acute illness influences
the patient’s initial acuity prioritization (triage level) and ED bed assignment. In addition, it is
important to consider that frequently multiple patients present at the same time for evaluation
and treatment in the ED resulting in potential delays in ED bed availability. For the purposes of
this study these influencing factors were not evaluated but should be considered for future
studies. ED throughput or ED bed availability as well as in-patient bed availability also impacts
the ED LOS and is a challenge worldwide. These throughput challenges can potentially
contribute to the quality of care provided to patients seeking care in the ED. As Clark and
Normile (2007) noted in a 2003 Government Accounting Office report the most common cause
of delayed admission to the hospital was holding admitted patients in the ED due to a lack of
critical care bed availability. The ED is simply not designed or staffed to care for patients over
extended periods of time, especially critically ill or injured patients (Chalfin et al., 2007).

Antibiotic Administration
Overall, the number of ED patients with severe sepsis who received antibiotics within 60
minutes or less as required by EDSSAPP did not improve across the three time cohorts, T0
(81.8%), T1 (71.7%) and T2 (80.6%). There are several unknown external factors that may have
contributed to the variability in the number of patients who received antibiotics as required by
EDSSAPP, (competing patient acuity priorities, increased ED patient volumes, difficulty
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obtaining venous access, etc.) that may have influenced the nurses’ availability to administer the
ordered antibiotics. Administering antibiotics within one hour in any busy emergency department
is a formidable task as reflected in the literature and not successful until organized and
systematic approaches are taken with consistent data review and follow up with providers
(Zubert 2010).
In a study by Powell, Khare, Courtney and Feinglass (2007) they found that sepsis
patients admitted through an ED having received an initial assessment and initiation of treatment
had a lower mortality rate (17.1%) than sepsis patients who were made a direct admit to an inpatient bed not coming through the ED (19.7%). While this study provided mixed results and the
ED continues to work towards more consistent adherence to EDSSAPP the care provided in the
ED is a valuable contribution to improving outcomes for this patient population.

Implications
ED throughput is a challenge nationwide as noted in the literature. The longer patients are
held in the ED awaiting placement to in-patient beds, the greater the chance for poor outcomes
(Clark & Normile 2007). These poor patient outcomes are most likely secondary to the lack of
ED staff and expertise to provide care for patients over prolonged periods of time; this is
especially true of critically-ill or injured patients (Chalfin et al., 2007). The ORMC ED admits
approximately 30% to 37% of its daily volume of patients. When the hospital has a high inpatient census, this can increase the time for notification that an in-patient bed is ready to receive
an ED patient for admission. It may have been beneficial to review hospital census data at T0, T1
and T2 to determine its impact on admission delays. Increased ED LOS therefore could have a
negative influence on the time to treatment initiation for one or more ED patients. Any decrease
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in ED LOS could increase the ED’s ability to potentially initiate treatment for other ED patients.
The average daily census in this ED is 200 patients, which is approximately eight patients treated
every hour. For every hour that a patient is held in the ED awaiting a ready in-patient bed, the
ED could have initiated treatment for up to eight patients waiting for evaluation and treatment. In
addition to the potential delay in care holding admitted patients can cause, there is also a possible
loss of revenue for the hospital as patients frustrated with long waits leave the ED without being
seen and treated.
One surprising result from this study was found in the evaluation of patient
chief/presenting complaints. The number of patients with skin/wounds diagnosis increased from
baseline (p < .001). Patients were assigned to this category based upon the following complaints:
abscess, multiple wounds, gangrene, decubitus ulcers(s), infected dialysis catheters and general
wounds. As seen in Chapter 4, this category had zero in T0, six in T1 and three in T2. The
meaningfulness of this finding given the small number of patients assigned to this category is
unclear and needs further investigation in future studies. However, from a clinical perspective
communicating this finding to ED staff may increase awareness for possible sepsis in all patients
presenting with existing wounds and other complaints as listed in this category.

Study Limitations
Several limitations should be considered when reviewing the EDSSAPP data results. The
first being, that this study was conducted at one facility. While these results will be used to
improve care provided in this ED they are not generalizable to other facilities. Following the
analysis it was apparent that there were some data that were not included in EDSSAPP that
might have enhanced this study. These include patient comorbidities, hospital acquired
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infections/injuries and patient acuity levels. In addition, the individual components of the
EDSSAPP order set and the ED and hospital census/capacity, during the different time cohorts
were not evaluated. This study did not examine the hospital critical shortage of in-patient bed
availability, also known “code green, yellow, red, and purple.” This is in part due to the
hospital’s lack of a process to accurately track the in-patient bed availability status. This process
was not taken into consideration for the purposes of this study, which is a limitation, but may be
an explanation for the increased hospital LOS for both alerts and non-alerts in Time 2. While
some findings were clinically significant, the sample size was small and not able to detect a
statistical difference given the effect size of the outcome variable which may have been different
with an increased sample size.

Recommendations for Practice
The results of this study will be used to help guide the ED CNS practice and be used
while EDSSAPP is reviewed and revised. Continued participation on the current corporate sepsis
committee will be an important part of the multidisciplinary collaboration needed to increase
awareness of and adherence to using the evidenced- based severe sepsis order set by the
attending physicians and residents. The committee is currently working on a program to track the
order set usage. This is a necessary first step toward the development of policies that require and
enforce individual provider accountability. On-going annual and periodic education will
coordinated with both corporate and unit based educators.
The CNS will also lead the refinement of the existing program to closely monitor the
SSA data and communicate these results in as close to real time as possible to the providers
involved in the care of the alerted patient. Select ED staff nurses have been provided special
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EMR access and training in order to assist in gathering data on each SSA and placing this
information into electronic spread sheet for calculations and results review. Increased
communication of these results to ED team members will escalate their awareness for
sepsis/severe sepsis and EDSSAPP, see ED Process Information Updates document Appendix
M. Improved collaborative efforts with the interdisciplinary team are needed to refocus
everyone’s efforts to improve early recognition followed by appropriate treatment interventions
and documentation is essential. In addition, a more formal team response to SSA’s similar to that
of Stroke or Trauma Alerts should be considered. Communication of the monthly audit results
could be posted for providers to review. This could assist in not only maintaining the awareness
of sepsis/severe sepsis but the potential need for improvement on crucial components of care for
this patient population. Lastly, the development of a formal process to follow up with individual
providers as close to real time as possible that includes accountability for care provided and
related documentation would also contribute to awareness and adherence. This accountability for
care provided following evidence-based guidelines and protocols is seen in other patient
populations (cardiac, stroke and trauma) and is being scrutinized by both third party payers and
regulatory agencies.

Recommendations for Future Research
As early recognition of sepsis is very important, it would be important to look at the time
of arrival to the time that sepsis was suspected and interventions were initiated. Does early
recognition of sepsis help to prevent patients from becoming severely septic and decrease
mortality? Can readmissions for sepsis/severe sepsis from local skilled nursing facilities (SNF)
be reduced by the implementation of a collaborative education effort between the hospital and
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SNF’s? In addition, the local EMS agencies have instituted their own Sepsis Alert process using
the SSC criteria, collaborative research with our pre-hospital partners related to their sepsis alert
process could improve coordination of care across the continuum.

Conclusions
The results of this study are consistent with what is seen in the literature with no new
findings. In order to promote acceptance and utilization of guidelines, they need to be developed
collaboratively with an interdisciplinary team, and once implemented, employed as intended to
improve patient outcomes. Healthcare leaders should not assume that just because a protocol
exists it will be used as intended. Protocols and guidelines must also be frequently reviewed with
the most current literature and be revised as new evidence is uncovered. Protocols and guidelines
are not intended to not replace the clinical judgment of the healthcare provider but rather to
enhance the care provided (Dontje, 2007). Healthcare professionals need to be receptive to
changing their practice, to using the most current evidence based guidelines even when this
challenges their traditional ways of practicing (Huang et al., 2007). Moving forward with an
organized, systematic and interdisciplinary approach has the best chance of succeeding in
changing practice and improving outcomes.
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APPENDIX A: SUMMARY OF 2008 SURVIVING SEPSIS CAMPAIGN
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Summary of the 2008
Guidelines for the Management of Severe Sepsis and Septic Shock
1.

2.

3.

4.
5.

SSC Guideline
Initial Resuscitation (first 6 hours)
Resuscitation to begin STAT in patients with
hypotension (SBP < 90), a change in Level of
Consciousness or Glasgow Coma Score, or
serum Lactate levels of 4 or greater.
Diagnosis: obtain 2 or more blood cultures and
cultures from other sites as clinically indicated.
Preform diagnostic imaging as indicated by
patient’s assessment/condition.
Antibiotic Therapy to begin within one hour of
recognizing severe sepsis/septic shock.

Infectious source identification and control
within 6 hours of arrival.
Fluid Therapy using crystalloids or colloids.

6.

Vasopressors: should NOT be administered as
an initial treatment for a hypotensive state.

7.

Inotropic Therapy to be considered cautiously
in patients with known cardiac dysfunction.
Steroids are to be considered in patients with
hypotension not responsive to fluid therapy or
vasopressors.
Blood Products: transfuse RBC’s when Hgb is
between 7-9 g/dL; administer platelets only
after carefully evaluating the patient’s levels
using SSC guideline ranges.
Mechanical ventilation may be necessary so
close and continual evaluation of both airway
and ventilatory efforts are important.
Sedation should be used especially in
mechanically ventilated patients.
Glucose control using frequent and accurate
glucose measuring and intravenous insulin.
Renal replacement may be necessary/helpful in
treating severe sepsis/septic shock.
Bicarbonate therapy not recommended for
treating severe sepsis/septic shock.
Deep Vein prophylaxis using either low
molecular weight heparin or a mechanical
prophylactic device.
Stress Ulcer prophylaxis using H2 blockers or
proton pump inhibitors.
Consideration for limitation of medical support
based on realistic expected patient outcomes.

8.

9.

10.

11.
12.
13.
14.
15.

16.
17.

Recommendations
Do NOT wait to begin care until the patient reaches inhouse bed.
Goals are to return patient to a hemodynamic stable
status.
If possible obtain all cultures prior to administration of
antibiotics. However DO NOT delay administration of
antibiotics if obtaining cultures is difficult or delayed.
Use broad spectrum therapy chosen based on the
suspected cause. May consider multiple or combination
medications based on co-morbidities and or patient
responses. STOP antibiotic therapy if cause found not to
be bacterial or known to be susceptible to current
medication.
Remove all medical devices suspected or shown to be the
cause or contributing to the cause of infection.
Rapid and large volumes may be necessary to stabilize
hemodynamic status.
If the patient does not positively respond to the
administration of IV fluid then consider using
norepinephrine or dopamine before any other pressors.
Suggested medication for this patient population:
dobutamine.
Steroidal therapy should only be used as long as
absolutely necessary and patients must be weaned off
this medication.
Important to NOT use erythropoietin in an attempt to
treat anemia in septic patients. Frequently monitor
laboratory results and adjust care as indicated.
Interventions depend on patients’ condition and
responses to treatment, PEEP may be required in these
patients.
Follow critical care sedation protocols, avoid paralytics
and closely monitor patient.
Caution with POCT as individual clinician technique can
influence quality of results.
Continuous veno- venous hemofiltration can be helpful
in unstable septic/septic shock patients.
Improve acidotic state in these patients via infusion of
fluids and correction of cellular acidosis.
May consider using a combination of therapies
depending the patients risk for DVT.
Benefits of long term prevention of GI bleeding
important to consider along with prevention of VAP.
Living Will and HealthCare Surrogate designation
should be completed prior to serious illness.
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APPENDIX B: PERMISSION FOR USE OF THE IOWA MODEL FIGURE
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APPENDIX C: SURVIVING SEPSIS CAMPAIGN INITIAL RESUSCITATION
BUNDLE
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2008 Six Hour Surviving Sepsis Campaign
Resuscitation Bundle Summary
This six hour resuscitation bundle is a combination of evidence-based clinical goals that must be
completed within 6 hours of identifying severe sepsis or septic shock.
1. Measure serum lactate.

2. Obtain blood cultures prior to antibiotic administration (if possible).

3. Administer broad-spectrum antibiotic within 3 hours of arrival to ED or within 1 hour of
non-ED admission.

4. Treat hypotension and/or elevated lactate with intravenous fluids (initial minimum of 20
mL/kg of crystalloid).

5. Administer vasopressors for hypotension not responding to initial fluid resuscitation to
maintain mean arterial pressure (MAP) >65 mmHg.

6. Administer vasopressors for hypotension not responding to initial fluid resuscitation to
maintain mean arterial pressure (MAP) >65 mm Hg.

7. Maintain central venous pressure (CVP) of >8 mm Hg.

8. Achieve and maintain central venous oxygen saturation (ScvO2) >70% or mixed venous
oxygen saturation (SvO2) >65%.
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APPENDIX D: EMERGENCY DEPARTMENT SEVERE SEPSIS ALERT AND
PRACTICE PROTOCOL
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Orlando Regional Medical Center
Emergency Department
SEVERE SEPSIS ALERT GUIDELINES
PLEASE NOTE: Nothing replaces professional CLINICAL JUDGEMENT when
evaluating patients. If SEVERE SEPSIS IS SUSPECTED and the patient is not in an ED
treatment bed yet INITIATE TREATMENT and notify the charge nurse STAT.
Pre-Hospital/ Emergency Medical Services Process
•

When recieving an EMS radio report complete the Severe Sepsis screening section on the
EMS report form. If positive notify the Charge nurse STAT.

•

Patients presenting via EMS with Suspected Severe Sepsis will be seen immediately by
the ED staff. If assigned to an ED treatment area the appropriate RN will follow the ED
Severe Sepsis guidelines. If no ED treatment bed is immediaetly available the ED
paramedic will notify the ED charge nurse STAT and follow the ED Severe Sepsis
guidelines.

Emergency Department Process
•

Patient arrives in ED: Assessment and Severe Sepsis screening are completed and triage
category is assigned (suspected severe sepsis patients are triage category 1 or 2). All
appropriate documentation in Sunrise will be completed.

•

If the patient is not already in or assigned to a treatment bed notify the charge nurse
STAT for bed assignment. The EDMD will be notified immediately that a suspected
severe sepsis patient is in the department. Remember, the severe sepsis patient is a
priority and treatment should begin immediately. Antibiotics should be given within one
hour of being ordered. When available an ED phlebotomist will respond to assist with
drawing blood and obtaining blood cultures.

•

The EDMD will evaluate the patient promptly and if severe sepsis is suspected initiate a
SEVERE SEPSIS ALERT and appropriate Severe Sepsis Order Set.

•

When central line placement is initiated, every effort will be made to strictly adhere to
hospital policies, including all necessary preparations and time out procedures.

•

After initial resuscitation has been initiated consider obtaining other cultures as necessary
ie: sputum or from existing wounds.

Patient Care Coordinator (PCC) process:
•

All of the PCC’s pagers will be activated when the “22” process for SEVERE SEPSIS
ALERT is initiated.
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•

The PCC’s office will call the ED “C” desk to acknowledge the SEVERE SEPSIS
ALERT and get all necessary information from the ED regarding the patient’s condition
and type of bed needed for admission.

Respiratory Therapy process:
•

Once the SEVERE SEPSIS ALERT page is received the ED respiratory therapist will
respond to the ED bed where the patient is being treated to obtain, if ordered, STAT
ABG’s and perform POCT arterial lactate, if no ABG’s are ordered the RT will run a
STAT POCT venous lactate. RT will do an ETCO2 evaluation and assist with any
necessary respiratory support the patient may require.

Radiology process:
•

Upon notification of a SEVERE SEPSIS ALERT the ED radiology technologist will
respond to the ED bed where the patient is being treated to perform STAT any diagnostic
radiology testing as required.
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Orlando Regional Medical Center
EMERGENCY DEPARTMENT “SEVERE SEPSIS ALERT” PAGER LIST

1. ED Respiratory Therapsist
2. Patient Care Coordinator
3. ED staff nurse professional pager
4. ED Clinical Nurse Specialist
5. ED radiology
6. ED PharmD
7. ED phelbotomist
ED Secretary notifications:
1. Senior ED Resident on duty
2. Hospital Pharmacy
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APPENDIX E: EDSSAPP POSTER
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APPENDIX F: LITERATURE REVIEW SUMMARY
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Authors/Year
Arnold, R.,
Shapiro, N., Jones,
A., Schorr, C.,
Pope, J., Casner,
E., Parillo, J.,
Dellinger, R.,
Trzeciak, S.

Discipline

Methods

Sample/Setting

Findings

Medicine

Using a standard
data collection
document
analyzed
consecutive ED
patients diagnosed
with severe sepsis
between 20042007.

Patients 17 or
older meeting
consensus
definitions for
severe sepsis from
a research
collaborative of 3
urban hospitals.

A total of 166
subjects met
criteria. Overall
mortality was
23%. Mortality of
the non-clearance
lactate group was
60% and 19% in
the lactate
clearance group.
An important
contributing factor
to survival is early
lactate clearance.

Medicine

National
Telephone Survey
with both
quantitative and
qualitative analysis

24 Emergency
Medicine directors
and 40 ED nursing
managers from 25
of the US most
densely populated
areas.

Both the medical
directors and
nursing managers
identified multiple
barriers to
implementing
components of the
SSC resuscitation
bundles. One
factor seen as
critical is the
nursing shortage.
Also noted was
challenged in
recognition of
sepsis. Only 7% of
EDMDs
acknowledged
using EGDT.

2008

Carlborn, D.,
Rubenfeld, G.
2007

2 of the busiest
teaching and 2 of
the busiest nonteaching hospitals
EDs.

Study authors
concluded there is
an increased need
for collaboration
between critical
care medicine and
emergency
medicine
physicians. The
ED is not the best
place for extended
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Authors/Year

Clark, K., Brush,
L. 2007

de Kruif, M.,
Limper M.,
Gerritsen, H.,
Speck, A.,
Brandjes, D., ten
Cate, H., Bossuyt,
M., Reitsma, P.,
van Gorp, E.

Discipline

Nursing

Medicine

2010

Dellinger, P.,
Levy, M., Carlet,
J., Bion, J., Parker,
M., Jaeschke, R.,
Reinhart, K.,

Medicine

Methods

Sample/Setting

Data were
collected between
2001-2003
retrospectively
from an ED
computer tracking
program, and the
corresponding inhospital program.
An exploratory
analysis of
secondary data
was conducted.

ED patients
admitted to the
ICU. (1,536)

Observational
study using
multiple logistic
regression analysis
was performed to
determine the
diagnostic value of
Procalcitonin
(PCT) in
diagnosing sepsis.

Patients 18 to 85
years old who
presented to the
ED with fever.

Using the Grades
of
Recommendation
Assessment
Development

N/A
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Large inner city,
level one trauma
center and tertiary
care hospital.

310 bed teaching
hospital.

Findings
care for critical
patients.
The greater the
time to first
medication
administration in
the ED the longer
the patients’
hospital stay.
Recognition of the
patient’s acuity
and
implementation of
intervention’s
impacted both
those who walked
into the ED and
those who arrived
via ambulance. ED
throughput and
multidisciplinary
collaboration are
important
contributing
factors.
211 patients met
criteria, 73 had
positive blood
cultures, 104 had
infection likely via
imaging and 34
had no infection
identified.
PCT can add value
as a biomarker for
sepsis when used
in conjunction
with c-reactive
protein and
clinician judgment.
International
experts agree and
evidence supports
the guidelines.
Rational is

Authors/Year
Angus, D., BrunBuisson, C., Beale,
R., Calandra, T.,
Dhainaut, J.,
Gerlach, H.,
Harvey,M.,
Marini, J.,
Marshall, J.,
Ranieri, M.,
Ramsay, G.,
Sevransky, J.,
Thompson, T.,
Townsend, S.,
Vender, J.,
Zimmerman, J.,
Vincent J.
2008
De-Miguel-Yanes,
J., Andueza-Lilli,
J., GonzalezRamallo, V.,
Pastor, L., Munoz,
J.

Discipline

Methods
Evaluation
(GRADE) tool the
SSC 2008
International
guidelines for the
management of
severe sepsis and
septic shock were
systematically
reviewed.

Medicine

Observational
study (only 2
months long)

A large university
medical center ED
(sees 515
patients/day)

Medicine

Determine the
estimated
effectiveness and
resource use when
implement ting the
SSC guidelines
from the hospital
perspective.

1000 Simulated
adult septic
patients.

Systematic review
of literature and
Medical Database
information.

N/A

2006

Huang, D.,
Clermont, G.,
Dremsizov, T.,
Angus, D. 2007

Jansen, T., van
Bommel, J.,
Bakker, J.

Sample/Setting

Medicine

2009

85

Findings
provided for each
recommendation.

Compliance with
EGDT guidelines
poor,
underestimated
severe sepsis in 17
Physicians in study patients while
Internal Medicine
overestimated in 2
NOT EDMDs
patients.

Simulation of the
average US ED.

While there is
financial
investment in
developing and
implementing a
process to initiate
EGDT for sepsis
patients the
decreased length
of stay and
mortality rates can
offset the initial
costs.
Review
determined that
lactate plays a role
in risk
stratification for
sepsis patients and

Authors/Year

Jones, A., Troyer,
J., Kline, J.

Discipline

Medicine

Methods

Economic data
analysis.

2011

Sample/Setting

Findings
suggested further,
more rigorous
study of its use.

2 groups used the
first one from 1
year before EGDT
was implemented
and the 2nd from 2
years after.

After very
complex
calculations it was
determined that
implementation
EGDT is cost
effective when
calculating in the
patient’s life
expectancy and
quality adjusted
life years
(QALYs).

Single center
study.

Jones, A., Shapiro,
N., Roshon, M.
2007

Medicine

Sepsis process
implementation
with pre and post
process
evaluations.

Septic and septic
shock patients
admitted via the
ED.
3 large urban
hospitals ED’s

86

Each facility
encountered its
own set of
challenges and
barriers. The
authors concluded
that only an
estimated 50% of
ED patients in the
US receive the
recommended
EGDT care for
sepsis as
healthcare
providers are slow
to accept these
standards.
Common
conclusions
included that each
facility needed to
use resources and
staffing
appropriate for
their individual
needs, each
facilities medical
staff both ED and

Authors/Year

Lagu, T.,
Rothberg, M.,
Nathanson, B.,
Pekow, P.,
Steingrub, J.,
Lindenauer, P.

Discipline

Methods

Analyzed the
amount of money
spent by the
facility on sepsis
and compared to
the mortality of the
population.

Between June 1.
2004 to June 30,
2006 reviewed
166,931 septic
patients’ records
from 309
hospitals. The
majority of
hospitals were in
urban locations,
half were in the
southern US.

The authors used
complex data
analysis and
concluded there
was NO
relationship
between spending
more for sepsis
care and improved
patient outcomes.

Medicine

Prospective
observational
study looking at
the prognostic
value of
Procalcitonin, CReactive protein
and Mortality
Scoring (MEDS)
on septic ED
patients.

Consecutive ED
patients meeting
SIRS criteria who
were >14 years
old.

The MEDS
scoring was a
predictor of
mortality and
Procalcitonin is
better in predicting
mortality than CReactive Protein.

A performance
improvement
initiative to look at
sites using the SSC
guidelines and the

Any hospital
worldwide
participating in
entering data into
the SSC site.

2008 Taiwan
Levy, M.,
Dellinger, P.,
Townsend, S.,
Zwirble, W.,
Marshall, J., Bion,

Findings
Intensive Care
were slow to adopt
EGDT, the
introduction of
new equipment
required extensive
training time and
availability was
not consistently
reliable. The
necessary follow
up to sustain the
programs used a
lot of resources
and time.

Medicine

2011

Lee, ChienChange, Chen,
Shey-Ying, Tsai,
Chu-Lin, Wu,
Shwu-Chong,
Chiang, Wen-Chu,
Wange, Jiun-Ling,
Sun, Hsin-Yun,
Chen, Shyr-Chyr,
Chen, Wen-Jone,
Hsueh, Po-Ren

Sample/Setting

Medicine

87

Emergency
department at a
university
affiliated facility
seeing >110,000
ED patients per
year.

Impression: there
is improving
compliance with
EGDT bundles and
decreased

Authors/Year
J., Schorr, C.,
Artigas, A.,
Ramsay, G., Beale,
R., Parker, M.,
Gerlach, H.,
Reinhart, K., Silva,
E., Harvey, M.,
Regan, S., Angus,
D.

Discipline

Methods
facility mortality.

Sample/Setting

Partnered with the
Institute of
Healthcare
Improvement to
develop bundles.

165 hospitals in 30
countries
participated with a
total of 15,022
patients data
included.

Retrospective
cohort study of
EGDT eligible
patients via EMR
review.

ED severe
sepsis/septic shock
patients in a
University Based
Hospital ED.

2010
Mikkelsen, M.,
Medicine
Gaieski, D., Goyal,
M., Miltiades, A.,
Munson, J., Pines,
J., Fuchs, B., Shah,
C., Bellamy, S.,
Christie, J.

2005 - 2007

2010

Findings
mortality in septic
patients.
Reviewers stated
this improvement
may be secondary
to the patients data
entered into the
site were not as
seriously ill as
protocol called for.
EGDT was
underutilized
despite the
documentation it
improves patient
outcomes.
Analysis of
EDMD’s showed
that EGDT was
less likely to be
initiated when the
MD was female
and had practiced
for years.
EGDT not started
42% of the time
and not completed
43% of the time.

Nguyen, B. H.,
Corbett, S., Steele,
R., Banta, J.,
Clark, R., Hayes,
S., Edwards, J.,
Cho, T., Wittlake,
W.

Medicine

2 year Prospective
observational
study.

Academic medical
center ED patients
meeting severe
sepsis/septic
shock.

A peer review
forum used with
the ED medical
director sending
letters to
individual MD’s
who did not
complete the
required EGDT
bundle on eligible
patients. It took 2
years to reach 50%
of implementation
compliance.

Medicine

Cross-sectional

National data

The greater the

2007

Powell, E., Khare,

88

Authors/Year
R., Courtney, M.,
Feinglass J.
2010

Shorr, A., Micek,
S., Jackson, W.,
Kollef, M.

Discipline

Methods
analysis of 2007
national in-patient
data.
Healthcare
Research and
Quality Agency:
healthcare cost
utilization project.

Sample/Setting
87,166 adult ED
patients who were
sepsis admits.
From 551 US
mainly urban
hospitals.

Medicine

Retrospective
analysis of before
and after a sepsis
protocol
implementation to
determine the
financial impact.

120 ED patients
with severe sepsis
or septic shock,
half before and
half after sepsis
protocol
implementation.
Academic hospital
emergency
department.

Medicine

Prospective cohort
study looking at
both clinical and
economic patient
outcomes.

Consecutive
patients presenting
in septic shock.

Discussion of
Sepsis and review
of literature related
to recognition and
treatment of sepsis
in the emergency
department.

N/A: Literature
review and general
discussion of
sepsis.

2007

Talmor, D.,
Greenberg, D.,
Howell, M.,
Lisbon, A.,
Novack, v.,
Shapiro, N.
2008

Vanzant, A.,
Schmelzer, M.
2011

Nursing

89

Emergency
Department and
Intensive Care
Units in an urban
facility with a
comprehensive
sepsis protocol in
place.

Findings
volume of sepsis
the better the care
the population
received. Authors
concluded
increased volume
equals improved
quality of care
secondary to
experience.
The median cost
per patient before
the protocol was
$21,985 and post
protocol cost was
$16,103. Use of
the protocol not
only saved live but
also decreased
overall hospital
costs.
The mortality of
the historical
control group was
9.4% higher than
the study group;
however the costs
associated to care
for the study group
was $8,807 higher
than the historical
control group.

General review of
Sepsis and the
challenges faced
by Emergency
Departments in
dealing with this
patient population.
Suggestion by the
authors for ED’s to
develop early
recognition and
treatment
protocols.

Authors/Year

Discipline

Weinert, C., Mann, Medicine
H.

Methods

Sample/Setting

Findings

Opinion Review

Purpose of review
was to examine the
lack of research
being brought to
the bedside.

New discipline
called
Implementation
Science was
developed using
principles from
sociology, mass
communications,
adult education,
informatics,
research
psychology and
management
theory. A new way
to look at the
evidence, confirm
its strength and
find a systematic
way to change
practice at the
bedside mainly in
the intensive care
unit.

Editorial

Review of multiple
studies looking at
reducing mortality
in septic patients
using EGDT.

Time is an
important factor in
the care of
critically ill or
injured patients. In
the sepsis
population
receiving the most
appropriate
antibiotic within
one of becoming
symptomatic
decreases
mortality.
Accomplishing
this in a busy ED
is challenging
without an
organized and
systematic
approach.

2008

Zubert, S., Funk,
D., Kumar, A.

Medicine

2010
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Time Cohorts
Alert Status
Variables
Size
Age
Range
Mean (sd)
Gender
Male
Female
Race
Caucasian
Black
Hispanic
Asian
Week Day
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Mode of
Arrival
EMS
Private Car
Shift Arrival
7a-7p
7p-7a
Alert Status
Alert
Non-Alert
C/O Systems
Metabolic
Neurologic
Respiratory
GI
Cardiac
Skin/Wounds
GU

All
All
Number
(%)
201
(100%)

Time 0
Non-Alert
Number
(%)
22
(10.94%)

Time 1
Alert
Non-Alert
Number
Number
(%)
(%)
19
26
(9.45%)
(12.93%)

19-102
62.42
(18.47)

23-90
59.86
(18.31)

23 – 93
62.37
(20.78)

19 – 88
53.62
(21.53)

19 – 95
64.95
(16.66)

29 – 102
62.43
(19.82)

103 (51.2)
98 (48.8)

9 (40.9)
13 (59.1)

14 (73.7)
5 (26.3)

17 (65.4)
9 (34.6)

57 (50.4)
56 (49.6)

6 (28.6)
15 (71.4)

116 (57.7)
60 (29.9)
21 (10.4)
4 ( 2.0)

14 (63.6)
4 (18.2)
3 (13.6)
1 (4.5)

13 (68.4)
6 (31.6)
0 (0.0)
0 (0.0)

14 (53.8)
8 (30.8)
4 (15.4)
0 (0.0)

65 (57.5)
36 (31.9)
10 (8.8)
2 (1.8)

10 (47.6)
6 (28.6)
4 (19.0)
1 (4.8)

15 ( 7.5)
36 (17.9)
33 (16.4)
32 (15.9)
32 (15.9)
25 (12.4)
28 (13.9)

2 (9.1)
6 (27.3)
2 (9.1)
2 (9.1)
2 (9.1)
7 (31.8)
1 (4.5)

0 (0.0)
4 (21.1)
4 (21.1)
1 (5.3)
6 (31.6)
1 (5.3)
3 (15.8)

3 (11.5)
4 (15.4)
3 (11.5)
6 (23.1)
5 (19.2)
1 (3.8)
4 (15.4)

9 (8.0)
19 (16.8)
24 (21.2)
18 (15.9)
14 (12.4)
12 (10.6)
17 (15.0)

1 (4.8)
3 (14.3)
0 (0.0)
5 (23.8)
5 (23.8)
4 (19.0)
3 (14.3)

136 (67.7)
65 (32.3)

17 (77.3)
5 (22.7)

19 (100)
0 (0.0)

18 (69.2)
8 (30.8)

71 (62.8)
42 (37.2)

11 (52.4)
10 (47.6)

127 (63.2)
74 (36.8)

13 (59.1)
9 (40.9)

12 (63.2)
7 (36.8)

17 (65.4)
9 (34.6)

69 (61.1)
44 (38.9)

16 (76.2)
5 (23.8)

132 (65.7)
69 (34.4)

0 (0.0)
22 (100)

19 (100)
0 (0.0)

0 (0.0)
26 (100)

113 (100)
0 (0.0)

0 (0.0)
21 (100)

56 (27.9)
51 (25.4)
31 (15.4)
18 (9.0)
12 (6.0)
9 (4.5)
3 (1.5)
21 (10.4)

4 (18.2)
8 (36.4)
5 (22.7)
1 (4.5)
3 (13.6)
0 (0.0)
0 (0.0)
1 (4.5)

6 (31.6)
6 (31.6)
3 (15.8)
0 (0.0)
0 (0.0)
1 (5.3)
0 (0.0)
3 (15.8)

4 (15.4)
6 (23.1)
4 (15.4)
3 (11.5)
2 (7.7)
5 (19.2)
0 (0.0)
2 (7.7)

38 (33.6)
29 (25.7)
13 (11.5)
11 (9.7)
7 (6.2)
1 (0.9)
2 (1.8)
12 (10.6)

4 (19.0)
2 (9.5)
6 (28.6)
3 (14.3)
0 (0.0)
2 ( 9.5)
1 (4.8)
3 (14.3)
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Time 2
Alert
Non-Alert
Number
Number
(%)
(%)
113
21
(56.21%)
(10.44%)

Other
WBC
Range
Mean
Antibiotic
Order
Yes
No
Lactate
Venous
Arterial
Not Done
Lactate Level
Range
Mean (sd)
ED LOS
Range
Mean (sd)
Hospital LOS
Range
Mean (sd)
Discharge
status
Home
SNF
Expired
Hospice
Home
Health
Rehab
AMA
Psych

0.5 – 84.5
15.21
(10.77)

5.1 - 33.5
15.84
(9.49)

0.5 – 54.0
13.92
(11.77)

1.6 – 43.0
15.66
(10.91)

0.5 – 84.4
15.53
(11.52)

5.2 -25.9
13.46
(6.49)

194 (96.5)
7( 3.5)

21 (95.5)
1 (4.5)

19 (100)
0 (0.0)

22 (84.6)
4 (15.4)

111 (98.2)
2 (1.8)

21 (100)
0 (0.0)

94 (46.8)
69 (34.3)
38 (18.9)

5 (22.7)
10 (45.5)
7 (31.8)

10 (52.6)
8 (42.1)
1 (5.3)

6 (23.1)
10 (38.5)
10 (38.5)

68 (60.2)
38 (33.6)
7 (6.2)

5 (23.8)
3 (14.3)
13 (61.9)

0.0 – 48.0
2.81 (4.26)

0.0 - 8.4
2.09 (.75)

0.0 – 8.9
1.53 (0.61)

0.0 - 15.0
3.05 (4.45)

0.0 – 48
3.15 (4.93)

0.0 - 6.2
1.14 (1.71)

54 – 1772
472.28
(261.24)

163 – 881
442.18
(182.70)

127 – 793
365.32
(196.498)

67 – 807
422.88
(202.92)

54 – 1772
487.81
(280.38)

173 -1442
578.19
(304.56)

1 – 91
10.11
(11.19)

1 – 60
11.95
(15.02)

1 – 43
9.00
(9.27)

1 – 43
9.00
(9.18)

1 – 91
10.48
(11.82)

1 – 21
8.57
(6.49)

66 (32.8)
61 (30.3)
42 (20.9)
14 (7.0)
12 (6.0)
3 (1.5)
2 (1.0)
1 (0.5)

6 (27.3)
7 (31.8)
5 (22.7)
2 (9.1)
2 (9.1)
0 (0.0)
0 (0.0)
0 (0.0)

2 (10.5)
10 (52.6)
6 (31.6)
0 (0.0)
0 (0.0)
1 (5.3)
0 (0.0)
0 (0.0)

9 (34.6)
4 (15.4)
9 (34.6)
0 (0.0)
3 (11.5)
0 (0.0)
1 (3.8)
0 (0.0)

41 (36.3)
33 (29.2)
21 (18.6)
11 (9.7)
3 (2.7)
2 (1.8)
1 (0.9)
1 (0.9)

8 (38.1)
7 (33.3)
1 (4.8)
1 (4.8)
4 (19.0)
0 (0.0)
0 (0.0)
0 (0.0)
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